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Abstract 
Jaco Jacobs 
Towards polypeptide based nanoparticles 
Research towards advanced materials is an area of high interest due to the ever growing 
technological demands from emerging applications in (nano)medicine, particularly the fields 
of biomedicine and biotechnology with applications ranging from tissue engineering, drug 
delivery and biodiagnostics. Polypeptides are envisioned to achieve a major impact on these 
areas due to the significant advances in the controlled ring-opening polymerisation of amino 
acid N-carboxyanhydrides (NCAs). This has fuelled opportunities for the design of well-
defined macromolecular structures whose physical, chemical and biological properties are 
ruled by their controlled sequences and composition. Moreover, efficient orthogonal 
functionalization techniques have further expanded the scope for the design of functional 
polypeptides. The aim of this PhD was to expand the reach of these synthetic materials to be 
utilized in existing technologies as green alternatives. Specifically, we wanted to incorporate 
polypeptides in the synthesis of nanoparticles as fully biocompatible and biodegradable 
surfactants or emulsifiers. To evaluate their viability as potential stabilizers, it was necessary 
to develop improved modular routes towards biohybrid materials and incorporate them in 
latex formation. Chapter 2 describes the synthesis of polypeptide–polymer hybrids via the 
combination of radical addition-fragmentation chain transfer (RAFT) mediated 
polymerization and the ring-opening polymerization (ROP) of NCAs. Key to this successful 
approach was an end-group engineering strategy that prevented the simultaneous presence of 
amino and chain transfer agent groups. This resulted in the synthesis of glycosylated 
amphiphilic block copolymers which were found to be efficient stabilizers in the emulsion 
polymerization of styrene, offering a facile method for the synthesis of fluorescent 
glycosylated polystyrene nanoparticles (Chapter 3). Chapter 4 expands this concept towards 
fully amino acid and sugar based emulsifiers in the preparation of functionalized polymer 
colloids. In the final part of the work (Chapter 5), we report on a pioneering strategy 
regarding the controlled synthesis of polypeptide based nanoparticles utilizing a scalable 
miniemulsion process.  This latter work is the culmination of the knowledge gained 
throughout the PhD which we feel has great potential as a next generation biodegradable 
carrier system.   
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Chapter 1 
Literature introduction 
Polymeric materials have been instrumental in the evolution of nanotechnology, an area 
which has evolved significantly due to the unique opportunities it offers to industries such as 
agriculture, food industry, cosmetics and medicine.
1-6
 Arguably the greatest driving force for 
the rapid technological advances in nanotechnology is the support it receives from both the 
pharmaceutical and biomedical industries. Research in the in the fields of diagnostic and 
therapeutic medical applications has led to fast paced innovation regarding the design of 
functional nanoparticles with the ability to target, encapsulate, transfer and/or controllably 
release the active species.
7-9
      
In the area of nanomedicine, polymer therapeutics is an interdisciplinary research field at the 
interface of polymer chemistry, medicine and cell biology/pharmaceutical sciences
10-12
  
Included in this collection of complex multifunctional polymer based drugs and carriers are 
polymeric micelles. These rely on the self-assembly of amphiphilic block copolymers into 
various three dimensional nanostructures such as micelles, vesicles, rods and worms.
13-16
 
However, compared to these nanoparticulate products, solid nanoparticles possess increased 
colloidal stability, better chemical resistance as well as ease of preparation. Currently, 
poly(lactic-co-glycolic acid) (PLGA) is one of the most promising materials utilized for the 
NP core due to its inherent biocompatibility and biodegradability.
17
 Furthermore, PLGA has 
been successfully combined with poly(ethylene glycol) (PEG) for several systems where NPs 
are typically prepared via nanoprecipitation or emulsification.
18-22
  
Non-degradable polystyrene and poly(methyl methacrylate) have also been successfully 
incorporated as the hydrophobic core in fluorescent NP systems.
23-25
 Solid polymeric 
nanoparticles such as these are prepared by mini-, micro-, and emulsion polymerization 
processes resulting in nanoparticles, nanospheres or nanocapsules.
6, 26, 27
 These systems are 
able to prepare narrowly defined NP distributions while being tolerant to a wide range of 
monomer using radical , anionic, polyaddition and polycondensation polymerization 
techniques.
22, 28
  
Size, shape and surface properties should be specifically tailored towards the final application 
as these are critical for in vitro and in vivo applications.
29, 30
  One of the main challenges in 
this process is an effective functionalization platform, necessary for targeting applications. 
Active targeting allows for the controlled accumulation of NPs at a desired site. This involves 
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the conjugation of targeting ligands to the exposed surface of NPs, which interact with 
receptors expressed on the targeted tissue. Targeting ligands, which have been successfully 
utilized thus far include antibodies, peptides, aptamers and carbohydrates (glycans).
31-35
 
Accordingly, research regarding synthetic strategies towards multifunctional polymeric 
nanoparticle scaffold is of great interest. This involves exploiting and combining synthetic 
tools to obtain NPs with high levels of control, utilizing biocompatible and biodegradable 
materials as well as preparing materials which allow for commercial scalability. It was the 
aim of the work presented in this thesis to contribute to this field of research by designing 
novel functional nanoparticles and demonstrate their potential use is biomedical applications. 
The tools used in this process are controlled radical and N-carboxyanhydride polymerisation 
for the surfactant synthesis as well as emulsion polymerization for the particle synthesis. 
These techniques will be briefly introduced on the following pages.  
1.1 Controlled Radical Polymerizations   
Commercially, free radical polymerization is the preferred synthetic method for a large 
variety of high molecular weight polymers. This is due to its inherent compatibility with a 
wide range of monomers, solvents and reaction conditions, which inadvertently allows for a 
robust polymerization technique.
36, 37
 In conventional free radical polymerization, this 
tolerance does, however, come at the price of limited control as far as architecture, topology 
and molecular weight distribution are concerned.  
Due to the drawbacks of conventional free radical polymerization, a large body of work has 
been done over the last decade to develop techniques, which allow for the synthesis of a 
diverse range of macromolecules with well-defined architectures, functionalities and control 
over the degree of polymerization. The techniques developed are described as 
living/controlled radical polymerizations (LRP).
38,39
 
 
Living polymerizations are seen as 
systems where the polymer chain can propagate in the presence of monomer but does not 
undergo termination or chain transfer reactions.  
The effectiveness of LRP techniques is due to their ability to combine the benefits of living 
anionic polymerization, i.e. designed molecular architecture, with the versatility and 
robustness of free radical polymerization. The key concept of LRP is the establishment of a 
reversible dynamic equilibrium between a low concentration of active species ( ), which are 
able to propagate and a high concentration of dormant species ( ) (Scheme 1.1). For a 
system to have a “living character” it is necessary that the equilibrium lies towards the 
P
XP 
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dormant species. This minimizes the concentration of active radicals present at any one 
moment thereby reducing possible radical-radical reactions, which inadvertently terminate 
growing chains. The consequence of this is that all the chains grow simultaneously thus 
giving the technique its “living” character.   
Initiator
M
kp
Pn
Pn +     X
kd Pn-X
ka
kd
Pn +     X
M
Pn Pm+ kt
k t
Dead chains
 
Scheme 1. 1 General mechanism for a living radical polymerization (LRP).  
The most commonly used LRP techniques as noted by various LRP reviews are NMP
40, 41
   
(nitroxide mediated polymerization), ATRP
42, 43 
(atom transfer radical polymerization) and 
RAFT 
44,45, 46 
(reversible addition-fragmentation chain transfer) mediated polymerization. 
The mechanism of NMP and ATRP differs vastly from that of RAFT mediated 
polymerizations as the former obtain the living character (of the system) by reversibly 
capping the growing radical chains with either nitroxide radicals (NMP) or via a redox 
process involving a metal halid salt (ATRP) to obtain the favoured dormant species (1 and 2) 
(see Scheme 1.2 and 1.3). 
 
 
Scheme 1. 2 The general mechanism of a nitroxide mediated polymerization  
  (NMP). 
P
H2
C C
Y1
Y2
O N
R1
R2
P
H2
C C
Y1
Y2
M + O N
R1
R2
kact
kdeact
1
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Scheme 1. 3  Mechanistic basis of atom transfer radical polymerization (ATRP). 
RAFT
45, 47
 mediated polymerization and a similar method, MADIX
48,49
 (macromolecular 
design via interchange of xanthates) were introduced roughly at the same time in 1998 by the 
CSIRO group and the Rhodia research group, respectively. Both these processes have the 
same reversible transfer mechanism and will both be referred to by the general term of RAFT 
mediated polymerization.   
1.1.1 RAFT mediated polymerization 
RAFT is arguably the most versatile synthetic tool available for synthesizing well-defined, 
high molecular weight heterotelechelic polymers. It is a facile technique that can be 
conducted under numerous reaction conditions, is compatible with a wide range of monomers 
and tolerant to various functional groups.
50, 51
  
Z S
R
S
R1 S
R
S
S S
R
S
O S
R
S
N S
R
S
R1 R1
R1
R2
Dithioester Trithiocarbonate Xanthate Dithiocarbamate
Free radical leaving group, R
(Must be able to reiniate polymerization and 
promote fragmentation)Reactive C-S double bond
Z-group controls reactivity of C-S double 
bond (radical addition and fragmentation) 
and stabilizes the intermediate radical
 
Figure 1. 1 General structures for commonly used RAFT agents. 
RAFT mediated polymerization is a degenerative process which acts via a two-step addition-
fragmentation mechanism. It has the inherent feature of being able to produce polymer with 
reactive/functional moieties at both the α- and ω-chain-end. This is achieved via the RAFT 
agent’s R- and Z-groups (Figure 1.1), which allows for the introduction of functionalities at 
P
H2
C C
R1
R2
X + MtXn / L P
H2
C C
R1
R2
M MtXn+1 / L+
kact
kdeact
2
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these chain-ends. The R-group is found at the α-chain end while the Z-group ends up at the ω-
chain end of the polymer, attached as a reactive thiocarbonyl thio moiety. It is possible to 
design a RAFT agent for each specific monomer, taking into account its reactivity. The R- 
and Z-groups, i.e. the re-initiating and activating groups, can mediate the polymerization to 
the extent of obtaining excellent control over chain-end functionalities and offering further 
modification possibilities.
52
  
1.1.1.1  The RAFT mechanism   
The fundamentals of free radical polymerization apply to the RAFT process where the rate of 
radical termination (Rt) is related to the square of the radical concentration ( ) and 
the rate of propagation is directly proportional to the radical concentration ( ). Thus 
to eliminate (decrease) termination and allow for a ‘living’ character, the radical concentration 
needs to be kept low. This is achieved via the addition of a controlling agent into the 
polymerization medium, which is able to create a rapid equilibrium between the active 
propagating radicals and the dormant polymeric thiocarbonyl thio compound (Scheme 1.4, ii 
and iv). This dynamic equilibrium ensures an equal probability for all the chains to grow 
resulting in narrowly dispersed polymers. 
2][  nt PR
][  np PR
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Scheme 1. 4 Mechanism of RAFT-mediated polymerization 
Initiation is identical to conventional free radical polymerization where radicals (3) are 
generated by decomposition of a free radical initiator, typically an azo type molecule such as 
AIBN. The initial transfer reaction between the active species (4) and the chain transfer agent 
(CTA) (5) leads to the addition to the reactive C=S bond of the chain transfer agent to 
produce a carbon centered intermediate radical (6). This species may undergo a β-scission 
reaction which can either yield the reactants back, or release the R-group as a radical fragment 
(8) and leave the polymeric chain capped with the initial active species thus forming the 
reversible, dormant species (7) (this stage is commonly referred to as the pre-equilibrium, 
Equation ii). The released R radical (8) can initiate a new chain by adding to the monomer or 
it can add back to the CTA producing the carbon-centered intermediate radical (6). 
The main equilibrium (v) takes place solely between propagating chains (active species) and 
macro-CTAs (dormant species end-capped with the CTA, 10), resulting in a rapid exchange 
of the CTA cap. The propagating radical chains rapidly exchange between the two dormant 
forms (10) and (12) and their actively propagating forms.  
Initiation
Initiator I
M M
Pn
Reversible chain transfer (propagation)
Pn
M +
Z
S S
R Pn
S S
R
Z Z
SS
Pn + R
Reinitiation
R M M M
ki
R M Pm
Chain equillibrium (propagation)
M +
Z
S S
Pm
S S
Pn
Z Z
SS
Pm +
kp
kp
Pn
Pm
Pn
Termination
Pn
Pn
Pn +
+
+ I
R
Pm
Dead polymer
Dead polymer
Dead polymer
i)
ii)
iii)
iv)
v)
vi)
vii)
kaddkfrag
kfragkadd
kaddkfrag
kfragkadd
3 4
5 6 7
10 11 12
8
8
9
13
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By using a minimal amount of initiator (only free-radical source, typically added at a 
concentration 0.1 to 0.2 times the RAFT agent concentration), termination reactions are 
minimized due to the resulting low concentration of the active species. Rapid exchange 
ensures that each chain has the same probability of growth, which is essential as all chains 
must be initiated early in the polymerization reaction for a narrow MWD. 
1.1.1.2  Choice of RAFT agent 
The structure of the RAFT agent is very important to the success of the RAFT process as the 
stability of the intermediate radical can be modified by selecting a particular Z- and to a lesser 
extent the R group. Subsequently, RAFT CTAs can only sufficiently control the 
polymerization of a certain type of monomer. In a comprehensive review by Moad et al.,
53
 
thiocarbonyl thio compounds that are used as RAFT agents in combination with certain 
monomer classes are reviewed and the efficient combination of CTA and monomer are given. 
These CTAs include dithioesters (Z = alkyl or aryl), trithiocarbonates (Z = thiol compound), 
dithiocarbamate (Z = dialkylamino) and xanthates (Z = alkoxy).  
1.1.1.3  The R group 
After the initialization step, the subsequently formed oligomeric radicals react with the RAFT 
agent to form the intermediate radical (6).  The R-group (leaving group) re-initiates the 
polymerization which, ideally with fast consumption of the RAFT agent and subsequent 
fragmentation, will result in most of the chains being initiated at the commencement of 
polymerization. The R-group should fragment at least as quickly as the polymer chains from 
the stabilized radical intermediate. This rapid interchange in the chain transfer step ensures 
that the concentration of growing radical chains is kept lower than that of the stabilized 
radical intermediates, thereby limiting termination reactions. 
The R-group is expected to have less effect on the kinetics of the reaction after initiation, as, 
after the addition of only one or two monomer units, the R-group does no longer influence the 
reactivity of the propagating polymer radical. 
1.1.1.4  The Z group 
The role of the Z-group is to control the stability of the intermediate radical by activating or 
deactivating the C=S double bond and thereby affecting the reactivity towards the incoming 
radical. The interplay between the reactivity of the incoming radical and the leaving ability of 
the R-group directly affects the concentration of the intermediate radicals and thus the extent 
to which these are involved in termination reactions.  
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Furthermore, the nature of the monomer has a great influence as these can be classified into 
two groups which effectively rate the activity of the monomer, i.e. “more activated” 
monomers (MAMs) such as such as styrene, methyl acrylate and methyl methacrylate 
compared to the “less activated” monomers (LAMs) which would then include vinyl acetate, 
N-vinylpyrrolidone, and N-vinylcarbazole. Generally RAFT agents suitable for the one type 
of monomer are ineffective for the other type as it results in retardation and/or inhibition 
during the polymerization process (Fig 1.2).
54
  
 
Figure 1. 2 Guidelines for selection of RAFT agents for various polymerizations. The 
addition rates decrease and fragmentation rates increase from left to right.
36
 
Thus, it is essential to select an appropriate RAFT agent. Poor transfer efficiency,
55
 slow 
reinitiating rate
56
 and a slow rate of fragmentation
57
 have been proposed as the main causes of  
lack of control when doing RAFT mediated polymerizations.     
1.2 Polypeptides via living ring-opening polymerizations of N-carboxyanhydrides 
Peptides and proteins play significant roles in our everyday lives. They are built from α-amino 
acids, connected via amide bonds.  Unfortunately, the synthesis of natural polypeptides 
(proteins) with well-defined amino acid sequences, are severely limited to low molecular 
weight polypeptides of minimal quantities. This is due to the synthesis method namely via 
solid-phase peptide synthesis (SPPS) i.e. a one-by-one amino acid addition via a solid-phase 
support.
58, 59
  
In contrast, the ring opening polymerization of N-Carboxyanhydrides (ROP NCAs) is a 
method, which allows for the synthesis of high molecular weight polypeptides with specific 
architectures in a highly controlled manner.
60-62
 This permits for the synthesis of structurally 
simplistic mimics when compared to their natural counterparts as they lack specific amino 
acid sequences, but still have the ability to form stable secondary structures (α-helices and β 
sheets) in solution via hydrogen bonding as well as hydrophobic, electrostatic and dipolar 
interactions.
63-65
   
Ph >> SCH3 ~ CH3 ~ N >> N
O
> OPh > OEt ~ N(Ph)(CH3) > N(Et)2
MMA VAc, NVC, NVP
St, MA, AM, AN
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The necessity for structural control over the synthetic polypeptides is evident in the 
importance it plays for proteins. It is the structural homogeneity in the sequences (primary 
structure) of these α-amino acids, which eventually determines their secondary structure and 
essentially needs to be a reproducible process when produced synthetically. Thankfully, 
significant advances in the controlled ROP of NCAs has fuelled opportunities for the design 
of well-defined macromolecular structures such as block
66-68
, graft
69
, star (co)polymers
70-73
 
and polymer brushes
74-76
 which shows parallels to the development in controlled radical 
polymerizations. These materials have shown their potential in an array of areas, non-more so 
than the biomedical fields with applications in tissue engineering, drug delivery and 
therapeutics.
77
      
1.2.1 NCA ROP Mechanisms 
The ROP of NCAs has two likely mechanisms agreed upon by various authors, dependent on 
the type of initiator used.
60, 61, 63
 The normal amine mechanism (NAM) entails that the 
initiator is a nucleophile with a mobile hydrogen atom. These include (primary and 
secondary) amines, alcohols and water, where the nucleophilic attack of the initiatior results 
in a carbamic acid intermediate which, after decarboxylation results in a terminal amino 
group. It is the formed primary amine that continues the propagation and allows for the 
formation of the eventual polypeptide (Scheme 1.5). Low dispersities can be engineered via 
the correct choice of initiator as seen with primary amines, where the latter’s reactivity 
exceeds that of the ω-amines of the propagating chains, resulting in the situation where ki > kp 
thus allowing all the chains to start growing simultaneously.
60, 61
 
 
 
Scheme 1. 5 The normal amine mechanism (NAM). 
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In the case where the initiator acts like a base instead of a nucleophile and abstracts a proton 
from the NCA, it is referred to as the activated monomer mechanism (AMM). Here an NCA 
anion forms due to the abstraction of a proton from the nitrogen atom of the monomer, which 
then attacks the carbonyl group in the 5-position (Scheme 1.6). Subsequently, this method is 
limited to NCAs with an unsubstituted nitrogen atom in the ring.  
 
Scheme 1. 6 The activated monomer mechanism (AMM). 
The effect of the two different mechanisms are clear when one compares achievable 
molecular weights as well as the control obtained. This is said to be due to the higher 
propagation rate of the anion which leads to higher molecular weight for AMM, but higher 
dispersities are expected due to ki < kp.
78
   
Lu et al. have shown the control one can obtain when exploiting this fact as they synthesized 
poly(benzyl-L-glutamate (PBLG) with high molecular weight but a low Đ using the 
secondary amine, N-trimethylsilyl amine. Thus allowing the functionalization at the C-
terminus, while still obtaining the control one expects of primary amines. The polymerization 
propagates via a trimethylsilyl carbamate (TMS-CBM) group which is unable to extract the 
proton of the nitrogen thus restricting the polymerization to the normal amine mechanism. 
Control of Đ = 1.1 is reported for PBLG (28 500 g/mol) using the selected initiators.79  
Although optimization of the reaction is possible via the choice of initiator, it is also possible 
to follow a more facile route by optimizing the NAM conditions and thereby trying to reduce 
possible side reactions as well as accelerating reaction rates. This includes lowering the 
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temperature
80, 81
 varying the solvent
82
 or possibly working at higher vacuum,
68, 83
  whereby 
the two greatest influences are arguably temperature and vacuum.  
Lowering the temperature essentially increases the stability of the carbamic acid intermediate, 
which after decarboxylation, forms the primary amine and subsequently propagates the 
polymerization.
61
 Kricheldorf et al.
82
 have shown that some solvents can induce 
polymerization of α-amino acids resulting in cyclic polypeptides while working at high 
vacuum results in the removal of CO2. This results in acceleration of the reaction as well as in 
minimization of possible side reactions that CO2 can have with the solvent.
61, 68
 
As mentioned before, the term ‘living system’ is used in the sense of the control achieved (Đ 
< 1.2) as well as the ability to reinitiate polymer chains in the presence of more monomer. 
Using this term loosely, Kricheldorf described the ROP of NCAs as ‘living polypeptides’ 
when using primary amines as the initiator.
60
 This was due to the fast initiation rate for small, 
unhindered amines, leading to excellent control as well as the ease of tailoring the degree of 
polymerization via the correct choice of the monomer/initiator molar ratio ([NCA]0/[I]0).  
This has allowed for a wider scope of possible implementation of polypeptides as the 
incorporation of other living polymerization techniques in combination with NCA ROP allow 
for the efficient tailoring of composition and topology.
84-86
 
1.3 Hybrid bioconjugates 
Due to the biological importance of polypeptides and the previous discussion on the living 
nature of the NCA ROP, it is evident that an array of applications is possible. This is 
especially true for their use in the fields of biotechnology, biomedicine and pharmaceutical 
technologies where the combination of natural- and synthetically prepared polymers allow for 
the synthesis of biohybrid materials, some of which have enjoyed clinical success.
11-13, 87
  
Several approaches exist for the preparation of hybrid conjugates, where typically a LRP 
technique is employed to synthesize the synthetic polymer and combined with the ROP of 
NCAs. The LRP techniques typically employed are ATRP, NMP and RAFT.
85, 88-91
  
Knoop et al. reported the combination of NMP and NCA ROP whereby they synthesized 
PBLG-b-PS using a dual initiator. The polypeptide was chain extended using a primary amine 
on the dual initiator and subsequently used as a macroinitiator. Macroinitiation of styrene via 
NMP yielded the narrowly dispersed and well-defined hybrid copolymer (see Scheme 1.7).
85
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Scheme 1. 7 Synthetic pathway to P(BLG-b-styrene) from a dual initiator.
85
 
The synthesis of polymer hybrids via ATRP and NCA ROP is well documented and recently 
Liu et al. have shown ability of preparing these conjugates with complex architectures such as 
molecular bottlebrushes. They synthesized Nϵ-bromoisobutyryl functionalized Nα-CBZ-L-
lysine and converted this to a polymerizable NCA. This was subsequently polymerized using 
a transition metal and the subsequent bromo-functionalized poly-L-lysine backbone was used 
to further grow styrene and ethylene glycol methacrylate side-chains (Scheme 1.8).
92
 
 
Scheme 1. 8 Synthetic route to poly(Br-L-lysine) (PBrLL) (P1), PLL-g-PS (P2), and 
PLL-g-PEGMA (P3) polypeptide bottlebrushes.
92
  
The use of RAFT in combination with NCA ROP has some inherent difficulties as the amino 
group used to initiate the NCAs will also cleave the thiocarbonyl thio moiety of the CTA via 
aminolysis. Furthermore, the resulting free thiol has the ablility to further act as a initator, 
albeit in an uncontrolled manner.
91
 Few modular routes are available as it needs effective 
tailoring of the CTA as well as a strategy which prevents the simultaneous presence of amino 
and CTA groups. Zhang et al. accomplished this with a new class of RAFT agents. A Boc 
protected amine is incorporated in to the RAFT CTA via a multi-step synthesis procedure 
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(Scheme 1.9).
93
 The applicability of using a polypeptide macroCTA is compared to using a 
synthetic PNIPAM macroinitiator to chain extend BLG NCA. Well-defined PBLG-b-
PNIPAM conjugates were prepared when utilizing the macroinitiator route where the thermo 
responsive properties of the hybrid where further investigated.  
 
Scheme 1. 9 Synthesis if the Boc protected RAFT CTAs. 
a Reagents and conditions:  (a) 
DCC, HOSu, DCM, −15 °C, 12 h (95%); (b) N-Boc-ethylenediamine, TEA, −10 °C ,12 h 
(90%); (c) TFA, 0 °C,1 h (70%).
93
 
The structures formed via the self-assembly of these hybrid conjugates are able to utilize the 
polyelectrolyte type character of the polypeptide which allows for reversible transitions. Thus, 
at a certain pH, the chains can be ionized and present as water-soluble coils or neutral with a 
secondary structure that will always favour certain secondary conformations leading to 
decreased solubility. This, in combination with amphiphilic block copolypeptides or 
amphiphilic polymer-protein conjugates, make for interesting self-assembled structures such 
as vesicles,
94-96
 aggregates,
94
 micelles
97, 98
 and organogels.
86
  
1.4  Latex particles via heterophase polymerization techniques   
1.4.1 Emulsion Polymerization  
Emulsion polymerization is arguably one of the most utilized tools in the preparation of 
polymer latexes where applications range from industrial uses such as surface coatings, paints 
or bulk polymers to (bio)medical fields like nanomedicine for the design of nanosized 
diagnostic agents. There is a real incentive to use water as the dispersion system as it is ideal 
for large-scale productions being an inexpensive, environmentally friendly solvent which 
allows for excellent heat dissipation during the polymerization.
99, 100
 
A simple system will typically start as an oil-in-water dispersion of monomer droplets in 
aqueous solution and once initiated, lead to a dispersion of polymer particles with mean 
diameters ranging from 50 – 500 nm. Sparingly water-soluble monomers such as styrenics, 
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acrylates and methacrylates are incorporated and partially stabilized by the addition of a 
stabilizer (above the critical micelle concentration). Colloidal stabilizers may be surfactants 
ranging from ionic, non-ionic or mixed systems to surfactant-free emulsions where high 
molecular weight polymer are incorporated in the particle and extend outward in a stabilizing 
capacitance, ensuring colloidal stability. Initiators are generally water-soluble, i.e. persulfates, 
ensuring that initiation starts in the aqueous phase.
101, 102
 
Upon heating, the initiator decomposes and propagates with monomer in the aqueous phase. 
This is interval І (0 – 10% conversion) of an emulsion polymerization where the addition of 
several monomer units makes the oligoradicals sufficiently hydrophobic and they 
subsequently diffuse into micelles or polymer particles to intiate in the oil phase. Free radicals 
generated will preferentially enter the smaller unswollen micelles or polymer particles 
compared to the larger monomer reservoirs due to the favourable surface/volume ratios.  
 As the polymerization proceeds into interval ІІ (10 – 40% conversion), any 
stabilizer/surfactant from the aqueous phase or that part of micelles which have not been 
nucleated will disappear as they are absorbed by the growing polymer particles. As 
propagation of the polymer chain ensues, the micelles grow (swell) via the diffusion of 
monomer from the aqueous phase and monomer reservoir. In interval ІІІ (conversion > 40%) 
the polymerization has proceeded to a stage where all the monomer reservoirs are depleted 
and any remaining monomer is solely present in the polymer particles.
103
 The terminology for 
these intervals was defined by Smith and Ewart and the kinetics have been well documented 
(see Figure 1.3).
101, 104-107
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Figure 1. 3 Classical qualitative desorption of phases (intervals) І, ІІ and ІІІ as a 
function of the evolution of monomer conversion (X), rate of polymerization (dX/dt) and 
number of particles (N).
107
 
1.4.1 Mini-emulsion Polymerization 
In some cases, the mechanism of an emulsion polymerization is not adequate for the synthesis 
of more compex materials. It is then possible to modify the technique via the introduction of 
an external shear force which subsequently reduces the size of the monomer droplets resulting 
in the latter becoming the loci of the polymerization themselves. This is known as a mini-
emulsion polymerization, whereby the reaction mixture is readily formulated so that any 
aqueous mass transfer between droplets is considered negligible. Furthermore, this is an 
efficient method for templating particles as the final particle sizes are similar to the initial 
monomer droplet sizes (if only particle nucleation occurred).
22, 28, 108
  This concept was first 
introduced by Higuchi and Misra
109
 and subsequently utilized in the formation of polymeric 
nanoparticles by Ugelstadt et al.
110
  
A typical mini-emulsion would involve a continuous phase, a dispersed phase, emulsifier and 
a co-stabilizer. The continuous phase is normally an aqueous solution which influences the 
reaction through pH and ionic strength. The dispersed phase contains the monomer and very 
often the co-stabilizer. The latter having excellent solubility in the dispersed phase while 
being badly soluble in the continuous phase, act as an osmotic pressure agent inside the 
droplet. The emulsifier is a surface active compound dissolved in the continuous phase.  The 
emulsifier helps prevent coalescence during droplet formation as well as aggregation during 
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the polymerization itself. It has an direct influence on the final particels size, colloidal 
stability and surface characteristics of the final latex.
108
 Initiation can proceed in either the 
dispersed or continuous phase as long as the polymerization proceeds inside the monomer 
droplets. 
The greatest attribute of this technique is that particle nucleation is the main nucleating 
mechanism, meaning no monomer transfer takes place. Subsequently, an array of synthetic 
tools is available to polymerize the monomer in the droplets. These range from anionic 
polymerizations resulting in polybutylcyanoacrylate (PBCA) nanoparticles,
111
 cationic 
polymerizations for the synthesis of poly-p-methoxystyreneparticles,
112
 ring-opening 
metathesis polymerization (ROMP) in preparing polynorbornene nanoparticles
113, 114
 and step-
growth acylic diene metathesis (ADMET) polymerization leading to oligo(phenylene 
vinylenes) particles.
115
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Chapter 2 
Synthesis of polypeptide block copolymer hybrids by the combination of N-
carboxyanhydride (NCA) polymerization with RAFT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was published in the journal Macromolecular Rapid communications: 
Jacobs, J.; Gathergood, N.; Heise, A., Synthesis of Polypeptide Block Copolymer Hybrids by 
the Combination of N-Carboxyanhydride Polymerization and RAFT. Macromolecular Rapid 
Communications 2013, 34, (16), 1325-1329. 
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2.1  Abstract 
The synthesis of hybrid bioconjugates via the ring-opening polymerization (ROP) of N-
carboxyanhydrides (NCAs) using a synthetic macroinitiator is described. Poly(n-butyl 
acrylate), polystyrene and poly(N-isopropyl acrylamide) was synthesized (Ɖ < 1.1) using 
reversible addition-fragmentation chain transfer (RAFT) as the synthetic tool. A 
phthalimidomethyl tritiocarbonate RAFT CTA was used to prepare well-defined, end-
functional polymers, which after deprotection, resulted in amine terminal macroinitiators. 
The subsequent initiating systems could successfully be chain extended with ε-
benzyloxycarbonyl-L-lysine (ZLL) or γ-benzyl-L-glutamate (BLG) as the NCAs to produce a 
library of polymer-polypeptide conjugates. In doing so, we describe a novel procedure for 
directly synthesizing bioconjugates via a non-modular route without the need for excessive 
purification and isolation steps. 
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2.2. Introduction 
Protein-polymer conjugates have enjoyed increased awareness as promising materials in 
biomedicine, (nano)biotechnology and pharmaceutical technologies.
1-4
 In view of their 
potential, researchers are also investigating fully synthetic biohybrid materials in which the 
natural protein segment is replaced by a synthetic polypeptide. While these are structurally 
simplistic mimics, the ability of synthetic polypeptides to adopt secondary structures allow 
for an inherent method of directing the formation of self-assembly in copolymers on the 
nanoscale.
5-9
 Recent advances in controlled N-carboxyanhydrides (NCA) polymerization 
have significantly enhanced the capability to obtain synthetic polypeptides with well-defined 
molecular weight, polymer architecture and end-group fidelity.
10-13
 Moreover, efficient 
orthogonal functionalization techniques have further expanded the scope for the design of 
functional polypeptides for example, stimuli-responsive materials.
14-24 
 
Additional macromolecular diversity and consequently property modulation can be achieved 
by the modular combination of the synthetic polypeptide segments with other functional 
polymer blocks. First reports employed atom transfer radical polymerization (ATRP) in a 
macroinitiation approach from synthetic polypeptides rationalized by the broad range of 
polymerizable monomers available in this methodology.
25-29
 However, interference of the 
amide bonds with the catalytic system along with the added purification steps needed to 
remove the ATRP catalyst, supports the investigation of a possible alternative to ATRP.
26, 30, 
31
 The combination of NCA and nitroxide mediated polymerization (NMP) has shown 
promise, but the versatility of possible monomers using NMP is a drawback as well as the 
high temperatures required for NMP.
32, 33
 Ring-opening metathesis polymerization (ROMP) 
was also successfully applied in combination with NCA polymerization.
34, 35
 While both 
techniques show very good compatibility, the limited choice of ROMP monomers could be a 
restricting factor. In contrast, reversible addition-fragmentation chain transfer (RAFT)-
mediated polymerization is one of the most versatile and robust methods for synthesizing 
well-defined, high molecular weight polymers from a wide range of monomers.
36-40
 However, 
due to the inherent possibility of side reactions, there is minimal work reported combining 
RAFT and the ring-opening polymerization of NCAs. One challenge is the inherent 
instability of RAFT agents in the presence of primary amines either required as initiators for 
the NCA polymerization or present as polypeptide chain ends. Nevertheless, the combination 
of RAFT and NCA ROP has enjoyed some success, for example Zhang et. al. have shown 
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that it is possible to initiate NCAs with a thiol end-functional initiator.
41
 γ-Benzyl-L-
glutamate (BLG) was successfully initiated with an aminolysed RAFT CTA resulting, 
however, in a multimodal distribution of products. Furthermore, to the authors’ knowledge, 
only one direct method of obtaining a synthetic amine-functional macroinitiator and chain 
extending with NCAs has been reported.
42
 Synthesizing bioconjugates via a non-modular 
route thus calls for a carefully chosen synthetic pathway to ensure the efficiency of the 
macroinitiator. 
We report the synthesis of hybrid polypeptide polymers by facilitating NCA polymerization 
from a synthetic RAFT macroinitiator. A protected amine functionality was incorporated in 
the RAFT CTA for subsequent chain extension of the polypeptide. A library of polypeptide-
polymer conjugates could be built up by varying the synthetic polymers used as the 
macroinitiator and after the subsequent deprotection, BLG or ε-benzyloxycarbonyl-L-lysine 
(ZLL) was incorporated as the NCAs.  
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Scheme 2. 1: Synthesis of block copolymers combining RAFT and NCA polymerization. (a) 
n-butyl acrylate, AIBN, 2 h, 60 °C; (b) 2-aminoethanol (10 eq.), 12 h, r.t.; (c) DMF, NH2NH2 
(30 eq.), 2 h, 60 °C; (d) styrene or N-isopropyl acrylamide, AIBN, 16 h, 60 °C; (e) DMF, 2-
aminoethanol (5 eq.), hydroxylethyl acrylate (5 eq.), 24 h, r.t.; (f) DMF, NH2NH2 (30 eq.),  4 
h, 75 °C; (g) DMF or CHCl3, BLG or ZLL NCA. 
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2.3  Experimental Procedures 
2.3.1 Materials 
All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. γ-Benzyl-L-glutamate and ε-benzyloxycarbonyl-L-Lysine were supplied by Bachem. 
Anhydrous DMF, chloroform, ethyl acetate, methanol were used directly from the bottle 
under an inert and dry atmosphere.γ-Benzyl-L-glutamate (BLG) and ε-benzyloxycarbonyl-L-
Lysine (ZLL) NCA was synthesised following a literature procedure.
43
 Butyl 
phthalimidomethyl tritiocarbonate, RAFT CTA, was synthesized according to a literature 
procedure by Moad et. al.
44
 
 
2.3.2 Synthesis of PBA, PS and PNIPAM homopolymer using RAFT CTA (1). 
The homopolymer was prepared according to a literature procedure by Moad et. al.
44
  
The following is representative procedure. n-BA (10 g, 78 mmol), RAFT CTA 1 (230 mg, 
0.71 mmol) and AIBN (23 mg, 0.14 mmol) were placed in a Schlenk flask and degassed via 4 
freeze-pump-thaw cycles. The flask was immersed in a preheated oil bath (60˚C) and left 
under magnetic stirring for a 2 hour period. The reaction was quenched by cooling the 
reaction flask and exposing the polymer solution to air. The product, PBA, was then isolated 
by dialyzing against methanol using Spectra/Por dialysis membranes (MWCO, 1000 Da) for 
24 h at room temperature. The excess methanol was removed under high vacuum and the 
resulting polymer dried under vacuum. The product was analyzed by 
1
H NMR spectroscopy 
(CDCl3) and SEC. Conversion as determined via 
1
H NMR spectroscopy: 54%. Isolated yield:  
4.3 g.  
2.3.3 Synthesis of amine end-functional PBA, PS and PNIPAM. 
2.3.3.1  Synthesis of Amine end-functionalized PBA. Trithiocarbonate end-
functional PBA (4 g, 53 mmol) was dissolved in DMF (10 mL) and added to a 50 mL round-
bottomed flask equipped with a magnetic stirring bar. 15 Molar equivalents of 2-
aminoethanol was added and then left to stir for 6 hours at room temperature. The solution 
was purified by dialysis against methanol using Spectra/Por dialysis membranes (MWCO, 
1000 Da) for 24 h at room temperature. The thiolactone end-functional polymer was 
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recovered by removing the solvent under high vacuum. The product was identified via 
1
H 
NMR spectroscopy (CDCl3) and MALDI-ToF MS. Product 3.6 g, 90% yield. 
The subsequent thiolactone end-functional polymer (3 g, 40 mmol) was dissolved in 8 mL 
DMF and added to a 50 mL Schlenck tube equipped with a magnetic stirring bar. The 
reaction mixture was placed in a preheated oil bath of 60 °C and 30 molar equivalents of 
hydrazine (0.6 mL) was added. The reaction mixture was left under stir for 2 hours. The 
solution was purified by dialysis against methanol using Spectra/Por dialysis membranes 
(MWCO, 1000 Da) for 24 h at room temperature. The product was recovered by removing 
the solvent under high vacuum and further drying in a vacuum oven for 40 hours at 40 °C. 
The product was identified via 
1
H NMR spectroscopy (CDCl3) and MALDI-ToF MS. 
Product 2.6 g, 87% yield. 
General procedure for the synthesis of amine end-functional polystyrene and poly(N-
isopropyl acrylamide) via a One-Pot Aminolysis/Thiol-Ene Reaction. 
2.3.3.2  Synthesis of Amine end-functionalized PNIPAM. PNIPAM-TTC (1.0 g, 
0.18 mmol), triethylphosphite (0.30 g, 1.8 mmol) and 2-aminoethanol (0.43 mL, 9 mmol) 
were dissolved in 8 mL DMF. The solution was degassed with nitrogen and left to stir for 3 h 
at room temperature. After this time had elapsed, a solution of hydroxylethyl acrylate (0.81 g, 
9 mmol) and triethylamine (0.091 mL, 0.91 mol) was added via a syringe to the reaction 
mixture. The reaction mixture was left to stir for 24 h at 25 °C. The solution was purified by 
dialysis against DDI water using Spectra/Por dialysis membranes (MWCO, 1000 Da) for 24 h 
at room temperature. After lyophilization, the product obtained as a white powder was 
analyzed by 
1
H NMR spectroscopy (CDCl3) and SEC. Yield: 0.82 g. 
The subsequent phthalimide and hydroxyl end-functional polymer (0.6 g, 0.11 mmol) was 
dissolved in 5 mL DMF and added to a 50 mL Schlenk tube equipped with a magnetic 
stirring bar. The reaction mixture was placed in a preheated oil bath of 75 °C and 30 molar 
equivalents of hydrazine (0.17 mL) was added. The reaction mixture was left under stir for 4 
hours. The solution was purified by dialysis against DDI water using Spectra/Por dialysis 
membranes (MWCO, 1000 Da) for 24 h at room temperature. The resulting solution was 
lyophilized and the product collected as a white powder. The product was analyzed by 
1
H 
NMR spectroscopy (CDCl3) and SEC. Yield: 0.48 g. 
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2.3.3.3  Synthesis of Amine end-functionalized PS. A similar procedure was 
followed to prepare the amine end-functional PS. 
2.3.4 General Procedure for Synthesis of the Hybrid Block Copolymers via NCA ROP. 
2.3.4.1  Typical synthesis procedure of PBA-b-PZLL at room temperature: The 
NCA monomer of ε-benzyloxycarbonyl-L-Lysine (0.74 g, 2.4 mmol) was dissolved in 30 ml 
anhydrous chloroform in a Schlenk tube and degassed via three successive freeze-pump-thaw 
cycles and then backfilled with nitrogen. A solution of PBA-NH2 (200 mg, 0.027 mmol) in 2 
mL anhydrous chloroform was injected through a rubber septum with a syringe. The reaction 
was left to stir at room temperature overnight until the ZLL NCA had been completely 
consumed as monitored by ATR FTIR spectroscopy. The reaction mixture was concentrated 
under vacuum and precipitated into an excess of diethylether, filtered and dried under 
vacuum. The product was identified via 
1
H NMR spectroscopy (DMSO) and SEC. Yield: 
75%  
2.3.4.2  Typical synthesis procedure of PBA-b-PZLL at 0 °C: The NCA monomer 
of ε-benzyloxycarbonyl-L-Lysine (0.74 g, 2.4 mmol) was dissolved in 6 ml anhydrous DMF 
in a Schlenk tube. The solution was degassed via three successive freeze-pump-thaw cycles 
and kept under vacuum. The reaction flask was immersed in a 0 °C water bath and a solution 
of PBA-NH2 (200 mg, 0.027 mmol) in 1 mL anhydrous DMF was injected through a rubber 
septum with a syringe. The reaction was left to stir for several days until the ZLL NCA had 
been completely consumed as monitored by ATR FTIR spectrosocopy. The reaction mixture 
was precipitated into an excess of diethylether, filtered and dried under vacuum. The product 
was identified via 
1
H NMR spectroscopy (DMSO) and SEC. Yield: 70%  
Similar procedures were followed to prepare PBA-b-PBLG, PS-b-PZLL and PNIPAM-b-
PZLL. 
 
 
 32 
 
2.3.5 Methods 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance 400 (400 
MHz) in DMSO-d6 and CDCl3 as solvents. All chemical shifts are reported in parts per 
million (ppm) with tetramethylsilane (TMS) as an internal reference. 
Attenuated Total Reflection (ATR) FTIR measurements were performed on a Perkin-Elmer 
Spectrum 100 instrument. Spectra were obtained from 4 scans with a resolution of 2 cm
-1
 in 
the spectral region of 650 – 4000 cm-1. A background measurement was taken before the 
sample was loaded onto the ATR for measurement. Samples could be characterized in the 
liquid state without prior sample preparation.   
Size Exclusion Chromatography (SEC) was performed on an Agilent 1200 system in 
conjunction with two PSS GRAM analytical (8 x 300 and 8 x 100, 10 μ) columns, a Wyatt 
Dawn Heleos 8 multi angle light scattering (MALS) detector and Wyatt Optilab rEX 
differential refractive index (DRI) detector with a 658 nm light source. The eluent was DMF 
containing 0.1 M LiBr at a flow rate of 1 mL/min. The column temperature was set to 40 °C 
with the MALS detector at 35 °C and the DRI detector at 40 °C. Molar masses and 
dispersities were calculated from the MALS signal by the Astra software (Wyatt) using the 
refractive index increment (dn/dc) as determined or found in literature.
45, 46
 The specific 
refractive index increments for the colopymers were calculated relative to the ratio of the 
homopolymer. The dn/dc values used for PZLL and PBLG were 0.120 and 0.118 
respectively, while the synthetic and copolymer values are summarized in Table 2.1. All 
samples for SEC analysis were filtered through a 0.45 mm PTFE filter (13 mm, PP housing, 
Whatman) prior to injection.  
MALDI-ToF-MS analysis was carried out on a Voyager-DE STR form Applied Biosystems. 
The matrix used was trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile 
(DCTB) with potassium trifluoroacetic acid (KTFA) added as cationic ionization agent.  
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Table 2. 1 dn/dc values for the library of hybrid bioconjugates successfully prepared 
using synthetic macroinitiators synthesized via RAFT mediated polymerization. 
Entry Copolymera dn/dcb 
A PBA60-NH2 0.041 
1* PBA60-b-PZLL98 0.103 
2* PBA60-b-PZLL127 0.106 
3** PBA60-b-PZLL68 0.096 
B PBA60-NH2 0.041 
1** PBA60-b-PBLG49 0.115 
   C PS80-NH2 0.159 
1** PS80-b-PZLL 0.135
e 
   D PNIPAM62-NH2 0.094 
1** PNIPAM62-b-PZLL 0.105
e 
a
The DP was determined via 
1
H-NMR. 
b
dn/dc values where calculated based on the molar 
fraction of the individual homopolymer. 
e
Initial [NCA]/[MacroI] ratios were used for the 
dn/dc calculation. * Bioconjugate synthesized via the chain extension of the subsequent NCA 
in CHCl3 at RT. **Bioconjugate synthesized via the chain extension of the subsequent NCA 
in DMF at 0 °C.
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2.4  Results and Discussion 
Due to the incompatibility of amino groups used for NCA initiation and CTA for RAFT 
polymerization we adopted a strategy by which the RAFT polymerization was carried out 
first followed by NCA macroinitiation. A phthalimide functional trithiocarbonate (TTC)
44
 (1) 
was used as the RAFT CTA to prepare the synthetic polymer (Scheme 2.1). The robustness 
of RAFT in this process is evident from the range of monomers successfully polymerized to 
prepare poly(n-butyl acrylate) (PBA), polystyrene (PS) and poly(N-isopropyl acrylamide) 
(PNIPAM). Well-defined, narrowly distributed (Ɖ = 1.1) homopolymers were synthesized 
with a protected amine at the α-chain-end and a TTC moiety at the ω-chain-end. 
To further employ the polymers as macroinitiator in NCA polymerization, it was necessary to 
selectively and quantitatively cleave the TTC moiety before deprotecting the phthalimide as 
the amine would readily react via an aminolysis reaction. Purification is arguably the most 
important factor when synthesizing the macroinitiator as residual by-products will readily 
initiate the NCA ROP and any method should thus be straightforward and simple. The 
cleaving is achieved by reacting the TTC moiety with a nucleophile such as a primary or 
secondary amine.
47, 48
 During these post-polymerization reactions, it was found that 
aminoethanol was most suitable for the selective cleavage of the TTC moiety. This was partly 
due to the compound’s aminolysis efficiency, but more importantly the ability to completely 
remove the excess aminoethanol and the subsequent by-products by dialysis. Xu et. al. have 
shown that acrylates and specifically poly(methyl methacrylate) readily form a terminal 
thiolactone functionality after aminolysis of a dithiobenzoate end-functionality due to 
backbiting of the subsequent free thiol.
49
 This was also observed for the PBA with 
1
H-NMR 
and MALDI-ToF MS indicating complete thiolactone formation (Figure 2.1). This has the 
advantages as it circumvents possible side-reactions when deprotecting the amine as NCA 
propagation will not be able to proceed via the thiol as a possible nucleophilic initiator.
41
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Figure 2. 1: 
1
H-NMR spectra of poly(n-butyl acrylate) before (A) and after the selective 
cleavage of the TTC moiety (B) via an aminolysis reaction and subsequent phthalimide 
deprotection (C). MALDI-ToF mass spectra of the amine end-functional poly(n-butyl 
acrylate) (C) with insert of  experimental (top) and theoretical (bottom) results for DP = 35. 
The phthalimide was deprotected using 30 molar equivalents of hydrazine at an elevated 
temperature (dependent on the susceptibility of the homopolymer to side-reactions) resulting 
in the amine end-functional macroinitiator.
44
 The removal of the phthalimide can be 
quantified by the disappearance of the characteristic phthalimido aromatic signals between δ 
7.5 and 8.0 ppm (Figure 2.1, A1+2) as well as the appearance of the amine signal (Figure 2.1, 
I) (confirmed via a D2O shake). The efficiency of the PBA macroinitiator was investigated by 
chain extension using different NCA in anhydrous DMF or chloroform, respectively. In 
4650 4700 4750 4800 4850 4900
ISO: C1H4N1(C7H12O2)35C10H15O3S + (K)1
m/z
4770.0047
n = 36n = 35n = 34
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general, we found that the propagation rate is enhanced in chloroform, but due to 
solubilization problems this method is limited to only certain NCAs for example ZLL and 
BLG while working with low concentrations. Alternatively the macroinitiator was chain 
extended in anhydrous DMF at 0 °C under vacuum.
50
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Figure 2. 2: SEC traces of PBA60-b-PZLL127 (A), PBA60-b-PZLL98 (B) and PBA-NH2 (C).  
For the PBA (7500 g/mol) (4, Scheme 2.1) chain extension with ZLL NCA, polypeptide 
chains of 20 000 - 40 000 g/mol were targeted. The reaction in chloroform is rapid and 
reaches completion in less than 10 hours when targeting up to 120 repeat units. Furthermore, 
when characterized by SEC, no residual homopolymer is evident after chain extension and a 
monomodal distribution of the higher molecular weight bioconjugates is present (Figure 2.2). 
The reaction was repeated at low temperature in DMF due to the enhanced end-group control, 
which would be important for further NCA chain extension.
50
 Only 60 repeat units were 
targeted due to the long reaction times associated with 0 °C NCA polymerization (Figure 
2.3). 
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Figure 2. 3 SEC trace PBA60-b-PZLL68 (red) and PBA-NH2 (black) after chain extension 
in DMF at 0 °C. 
By referencing the methyl signal of the PBA (0.80 – 0.92 ppm, Figure 2.4) to the two-proton 
peak of the ZLL repeat unit (4.7 – 5.2 ppm) the molecular weights of the block copolymer 
could be determined via 
1
H-NMR spectroscopy. A good agreement was found between the 
theoretical and experimental values (Table 2.2).  
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Figure 2. 4 
1
H-NMR spectra of PBA-b-PZLL after chain extension with ZLL NCA (*, 
DMSO-d6; **, water). 
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The versatility of the PBA macroinitiator was further indicated by chain extending with BLG 
NCA (4, Scheme 2.1), resulting in a monomodal distribution of PBA60-b-PBLG49 conjugates 
(Figure 2.5). Once again, a monomodal distribution was obtained where the molecular weight 
compared well with the expected value.  
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Figure 2. 5 SEC trace of PBA60-b-PBLG49 (red) and PBA-NH2 (black) after chain 
extension in DMF at 0 °C. 
 
The strategy was applied to PS and PNIPAM in an effort to extend the bioconjugate library 
while using the same RAFT CTA. However, the synthetic pathway had to be modified 
slightly in order to cap the free thiol obtained during aminolysis to inhibit possible initiation 
of the NCAs and to prevent reaction of TTC with the amine.
41
 This was overcome via a 
simultaneous aminolysis/thiol-ene reaction with hydroxyl ethylacrylate, effectively allowing 
us to engineer the ω-chain-end by introducing a functionality of our choice by the selection of 
the acrylate (5, Scheme 2.1). 
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Figure 2. 6 
1
H-NMR spectra of PS-TTC before (black) and after (red) a simultaneous 
aminolysis/thiol-ene reaction, yielding hydroxyl end-functional PS. The bottom (blue) 
1
H-
NMR spectra indicates the signal disappearance of the amine protecting phthalimide moiety 
after hydrazinolysis (* indicates solvent peaks). 
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Figure 2. 7 
1
H-NMR spectra of PNIPAM before (blue) and after (red) a simultaneous 
aminolysis/thiol-ene reaction, yielding hydroxyl end-functional PS. The top (black) 
1
H-NMR 
spectra indicates the signal disappearance of the amine protecting phthalimide moiety after 
hydrazinolysis. 
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After the simultaneous aminolysis and thiol-ene reaction of both PS and PNIPAM, 
1
H-NMR 
spectra show the absence of the TTC proton signals (Figure 2.6 and Figure 2.7) while the 
subsequent SEC trace indicates no higher molecular weight shift due to disulfide coupling 
(Figure 2.8 and Figure 2.9). This is indicative of successful conjugation of the ene and the 
thiol end-functional polymer. 
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Figure 2. 8 SEC trace of PS before (black) the one-pot aminolysis/thiol-ene reaction as 
well as after amine deprotection (red) yielding the α-amine and ω-hydroxyl end-functional 
polymer. 
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Figure 2. 9 SEC traces of PS80-b-PZLL60 (D) and PS-NH2 (E). 
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Figure 2. 10 SEC trace of PNIPAM before (black) and after (red) the one-pot 
aminolysis/thiol-ene reaction, as well as the subsequent amine deprotection (blue) yielding 
the α-amine and ω-hydroxyl end-functional polymer. 
 
Subsequently, PS and PNIPAM macroinitiators of 8300 and 7000 g/mol respectively, were 
synthesized and chain extended with ZLL as the NCA in DMF. Both the PS and PNIPAM 
macroinitiators indicate effective copolymerization of the polypeptide chain as illustrated in 
both Figure 2.9 and Figure 2.11. The PNIPAM system did however display a lower 
molecular weight shoulder, indicating the presence of some starting material and effectively 
increasing the [NCA]/[MacroI] ratio.  
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Figure 2. 11 SEC trace of PNIPAM62-b-PZLL (red) and PNIPAM-NH2 (black). 
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Table 2. 2 Library of hybrid block copolymer successfully prepared using RAFT 
macroinitiators and NCA polymerization. 
Copolymer
a 
[NCA]0/[MI]0 
Reaction 
time (h) 
Mn
theo (b) 
g/mol 
Mw
(c) 
g/mol 
Mn
NMR (a)
 
g/mol Ɖ 
PBA60-NH2 - 2 - 8000 7500 1.1 
PBA60-b-PZLL98 90 8* 31 100 48200 33200 1.1 
PBA60-b-PZLL127 120 <10* 39 000 61100 40800 1.1 
PBA60-b-PZLL68 60 72** 23 200 31400 25300 1.1 
PBA60-NH2 - 2 - 8000 7500 1.1 
PBA60-b-PBLG49 45 72** 17 400 18100 20400 1.1 
  
 
 
    PS80-NH2 - 24 - 8700 8300 1.1 
PS80-b-PZLL 60 72** 24 000 29800 N/A 1.1 
  
 
 
    PNIPAM62-NH2 - 16 - 7300 7000 1.1 
PNIPAM62-b-PZLL 90 120** 30 600 58 100 N/A 1.2 
(a) Molecular weights and DP were determined by 
1
H-NMR using signals of the initiator and 
the polymer. (b) Theoretical Mn calculated using the original target [NCA]0/[MI]0 ratios. (c) 
Mw determined by SEC in DMF using Multi Angle Light Scattering with dn/dc values 
calculated based on the molar fraction of the individual homopolymer. (e) Initial 
[NCA]/[MacroI] ratios were used for the dn/dc calculation. * NCA chain extension in CHCl3 
at RT. ** NCA chain extension in DMF at 0 °C under high vacuum. 
2.5  Conclusions 
We have demonstrated the versatility of the synthesis of polypeptide-polymer hybrids 
combining RAFT and NCA polymerization. Key to this successful approach is an end-group 
engineering strategy that prevents the simultaneous presence of amino and CTA groups. We 
devised two such strategies, which are simple and highly efficient, i.e. the aminoethanol CTA 
removal with in-situ thiolactone formation for PBA and simultaneous aminolysis/thiol-ene 
reaction with hydroxyl ethylacrylate for PS and PNIPAM. The combination of these two 
polymerization techniques has shown to be effective in synthesizing a wide range of hybrid 
conjugates only limited by the compatibility of the RAFT CTA and monomer while the 
presented end-capping strategies allow the introduction of a range of functional end-groups. 
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Chapter 3 
Fluorescent latex nanoparticles with selective binding and imaging 
properties using amphiphilic glycosylated polypeptide surfactants. 
 
 
 
 
This work was published in the journal Macromolecules: 
Jacobs, J.; Byrne, A.; Gathergood, N.; Keyes, T. E.; Heuts, J. P. A.; Heise, A., Facile 
Synthesis of Fluorescent Latex Nanoparticles with Selective Binding Properties Using 
Amphiphilic Glycosylated Polypeptide Surfactants. Macromolecules 2014, 47, (21), 7303-
7310.   
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3.1 Abstract 
Block copolymers comprising a poly(styrene) and a poly(L-lysine) or poly(L-glutamic acid) 
block, respectively, were obtained by sequential Reversible Addition–Fragmentation chain 
Transfer (RAFT) and N-carboxyanhydride (NCA) polymerization. Subsequent partial 
glycosylation of the poly(L-glutamic acid) block with D-galactosamine (GA) and the poly(L-
lysine) block with lactobionic acid (LA) yielded block copolymers with a degree of 
glycosylation of 50 % and 35 %, respectively, in the poly(amino acid) block. These 
amphiphilic block copolymers were successfully employed as macromolecular surfactants in 
the emulsion polymerization of styrene to produce uniform 100-150 nm size nanoparticles 
with a poly(styrene) core and galactose containing poly(L-amino acid) periphery. 
Introduction of fluorescence was achieved by incorporation of Nile Red during latex 
formation and reaction of remaining lysine functionalities on the nanoparticle periphery with 
fluorescein isothiocyanate (FITC). The availability of the galactose units at the nanoparticles 
surface for selective binding was demonstrated by lectin binding experiments and binding to 
Chinese hamster ovary (CHO) cells. Confocal images of live CHO cells following incubation 
with fluorescent glycosylated nanoparticles confirmed that the nanoparticles bound strongly 
to the cell surface and could only be removed by addition of free lactobionic acid 
highlighting selective binding of the nanoparticles on the cell surface. This approach provides 
a straightforward route to highly fluorescent nanoparticles with selective binding properties 
for imaging applications avoiding particle post-modification. 
 
 
 
 
 
 
 
 49 
 
3.2 Introduction 
The interest in advanced nanoparticles has significantly increased recently with the 
technological demands from emerging applications in biomedical devices. In particular in the 
area of diagnostics, functional nanoparticles with high contrast imaging capabilities 
combined with highly specific targeting properties towards clinically relevant targets are 
sought.
1-4
 . Inorganic nanoparticles are well documented for these tasks where some examples 
include iron oxide nanoparticles (IONPs) as a contrast-enhancing agent of magnetic 
resonance imaging (MRI). The large surface area of IONPs are ideal for carrying drugs and 
genes, however, surface modification is necessary for binding enhancement as well as for 
effective stabilization to prevent aggregation.
5-7
 Fluorescent silica nanoparticles (FSNPs) are 
another example of inorganic optical probes whereby silica NPs are loaded with a fluorescent 
dye as probes for sensitive imaging of, for example, cancer cells.
8-10
  
Polymer based NPs offer a highly promising alternative to inorganic nanoparticles for 
diagnostic applications.
4, 11
 Most reported examples of polymer NPs rely on the self-assembly 
of amphiphilic block copolymers into various three dimensional nanostructures such as 
micelles, vesicles, rods and worms.
12-14
 One drawback of these structures is their dynamic 
nature, which could cause stability issues under application conditions. Moreover, protocols 
of self-assembly and functionalisation often require multiple steps, which could compromise 
scalability of the materials. Solid polymer NPs are a promising alternative as they combine 
characteristics of solid inorganic NPs with the synthetic variability of polymers. Poly(lactic-
co-glycolic acid)s (PLGA) have already been utilized for NPs owing to their excellent 
biocompatibility and biodegradability.
15
 As the core material, PLGA has been combined with 
poly(ethylene glycol) (PEG) for several systems where NPs are typically prepared via 
nanoprecipitation or emulsification.
16, 17
 Furthermore, non-degradable fluorescent polystyrene 
(PS) and poly(methyl methacrylate) NPs have also been investigated successfully offering 
higher long-term stability for in vitro and in vivo cell imaging.
18, 19
 In a specific example 
Landfester reported the synthesis of functional fluorescent polystyrene NPs by miniemulsion 
polymerization incorporating functional acrylates for colloidal stability and as potential 
handles for post-modification. Cell uptake was visualized by fluorescent spectroscopy.
19
 
A critical aspect is in the design to produce NPs tailored to its final application. Size, shape 
and surface properties are parameters that need to be tuned as these are critical for in vitro 
and in vivo performance.
20, 21
 Furthermore, diagnostic agents need to be specific in the 
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detection of compromised cells and for this reason active targeting concepts are desirable. 
This involves the conjugation of targeting ligands to the exposed surface of NPs, which 
interact with receptors expressed on the targeted cells. Targeting ligands, which have been 
successfully utilized thus far include antibodies, peptides, aptamers and carbohydrates 
(glycans).
22-26
                                            
 
Figure 3.  1 Schematic route for the synthesis of glycosylated poly(styrene) nanoparticles 
with selective binding properties. 
The latter has come to the forefront of the scientific community in the past number of years 
with the discovery that glycans regulate numerous biological processes such as cell 
communication, selective binding of other biological species among others, which makes 
glycochemistry an attractive tool in the design of materials for selective targeting.
27-29
 In 
particular complex (surface) glycoproteins are involved in biological binding events and this 
has inspired research into the development of simplistic synthetic glycoprotein mimics
30-37 
Of 
particular attraction are glycopolypeptides derived from the polymerization of amino acid N-
carboxyanhydrides (NCA) due to their ready availability and structural similarity to natural 
proteins.
38-48 
The successful formulation of these glycopolypeptides into bioactive 
nanomaterials has been demonstrated albeit mostly by self-assembly.
49-51
  
In this work we devise a novel one-step strategy to prepare glycosylated fluorescent 
polystyrene nanoparticles in an emulsion using glycosylated polypeptide-PS conjugates as 
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macromolecular surfactants. Its attractiveness lies in the fact that the glycans play a large part 
in stabilizing the polymer latex while at the same time are presented at the final nanoparticle 
surface available for selective binding (Figure 3.1). This approach overcomes challenges 
associated with the bioconjugation of polymer particles by post-modification or surface 
grafting. The obtained PS NPs have a glycosylated periphery, which provides molecular 
recognition capabilities demonstrated by the specific binding to lectin and Chinese hamster 
ovary (CHO) cells. 
3.3 Experimental Procedures 
3.3.1 Materials.  
All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. γ-Benzyl-L-glutamate and ε-benzyloxycarbonyl-L-Lysine were supplied by Bachem. 
Anhydrous dimethyl formamide (DMF), chloroform, ethyl acetate and methanol were used 
directly from the bottle under an inert and dry atmosphere. γ-Benzyl-L-glutamate (BLG) and 
ε-benzyloxycarbonyl-L-Lysine (ZLL) NCA was synthesized following a literature 
procedure.
52
 Butyl phthalimidomethyl trithiocarbonate (RAFT CTA 1) and the PS 
homopolymer (PS TTC) were synthesized according to a literature procedure by Moad et. 
al.
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3.3.2 Polystyrene-trithiocarbonate (PS-TTC) cleavage using Bu3SnH. 
 PS-TTC (1) (2.5 g, 0.46 mmol) was dissolved in THF (15 mL) and added to a 50 mL round-
bottomed flask equipped with a magnetic stirring bar. The mixture was degassed with 
nitrogen for 30 minutes before the addition of Bu3SnH (1.03 mL, 3.8 mmol) and AIBN (0.19 
g, 1.2 mmol). The reaction was left to stir for 3 hours at 60 ºC. The solution was purified by 
precipitation into a 400 mL 80/20 mixture of methanol/n-heptane under vigorous stirring. 
This was repeated and washed twice with the same mixture to remove any excess Bu3SnH. 
The product was identified via 
1
H NMR spectroscopy (CDCl3). Isolated yield: 2.1 g. 
3.3.3 Phthalimide deprotection to produce PS-NH2 (2).  
Phthalimide end-functional polymer (1.7 g, 0.31 mmol) was dissolved in 10 mL DMF and 
added to a 50 mL Schlenk tube equipped with a magnetic stirring bar. The reaction mixture 
was placed in a preheated oil bath of 70 °C and hydrazine monohydrate (0.28 mL, 20 molar 
equivalents Hydrazine) added. The reaction mixture was stirred for 3 hours. The solution was 
purified by precipitation into 300 mL methanol and subsequently washed twice with 
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methanol. The product was dried under high vacuum at 40 ºC and isolated as a white powder. 
The product was identified by 
1
H NMR spectroscopy (CDCl3) (see Fig 3.2). Mw: 4800 g/mol, 
Ɖ = 1.05, dn/dc = 0.159 mL/g. Isolated yield: 1.5 g. 
3.3.4. General procedure for the synthesis of hybrid block copolymers via NCA ROP.  
Chain extension of the PS-NH2 macroinitiator was done according to a method described in 
previous work.
54
 PS45-b-PBLG66: Mw: 18200 g/mol, Ɖ = 1.06, dn/dc = 0.192 mL/g (
1
H-NMR 
spectrum Figure 3.5, SEC Figure 3.4). PS45-b-PZLL73: Mw: 22300 g/mol, Ɖ = 1.07, dn/dc = 
0.129 mL/g (
1
H-NMR spectrum Figure 3.5, SEC Figure 3.3). 
3.3.5 Polypeptide deprotection.  
A general procedure was used for the deprotection of both the PBLG and PZLL pendant 
groups: PS45-b-PBLG66 (1.35 g, 7.4 x 10
-5 
mmol) was dissolved in trifluoroacetic acid (12 
mL) and a minimal amount of THF to improve solubility. A solution of HBr (33 wt. % in 
acetic acid) (3 mL, 15 mmol, 3-fold excess with respect to γ-benzyl-L-glutamate repeat 
units)) was added slowly to the reaction at 0 ºC. After 4 h, the solution was added to 200 mL 
diethyl ether and the precipitate washed several times with diethyl ether. The subsequent 
product was redissolved in a 0.5M NaOH solution (aqua) to obtain the polymer in the sodium 
salt form. The sodium salt polymer was dialyzed against double deionized (DDI) water using 
Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at room temperature. The 
product was lyophilized and isolated as a white powder. Yield: 0.80 g, 6.1 x 10
-5 
mmol, 82 % 
yield.  
3.3.6 Glycosylation 
3.3.6.1  PS45-b-(PLGA31-r-GA35)66 (5).  
Glycosylation of the carboxylic acid moieties was achieved according to a modified literature 
procedure.
44
 PS45-b-PLGA66 (0.75 g, 5.7 x 10
-5 
mol)  and galactosamine hydrochloride (0.43 
g, 2.0 mmol, 0.5 eq w.r.t. the glutamate repeating units) was dissolved in deionized water (12 
mL) and stirred for 15 min. 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium 
chloride (DMT-MM) (0.55 g, 2.0 mmol, 1 eq to Galactosamine HCl) was dissolved in 5 mL 
of deionized water and added to the reaction mixture. After stirring for 24 h at room 
temperature the reaction mixture was dialyzed against DDI water using Spectra/Por dialysis 
membranes (MWCO, 3.5 kDa) for 72 h at room temperature. The polymer was subsequently 
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lyophilized and isolated as a white powder. 
1
H NMR spectrum see Figure 3.6. Isolated yield: 
1.1 g. 
3.3.6.2  PS45-b-(PLL47-r-LA28)75 (6).  
A general procedure for 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC)/N-hydroxysuccinimide (NHS) coupling was employed to attach 
lactobionic acid to the lysine residues of the amphiphile.  Lactobionic acid (0.64 g, 1.8 mmol, 
0.35 eq w.r.t the lysine repeat units), EDC (0.45 g, 2.3 mmol, 1.3 equiv.) and NHS (0.43 g, 
3.7 mmol, 2 equiv.) were dissolved in 2 mL 10 mM MES buffer (pH 4.7) and stirred for 20 
minutes, then PS45-b-PLL73 (1 g, 7.2 x 10
-5 
mol in 8 mL of DDI water) added. The reaction 
mixture was stirred overnight. The resulting product was purified via dialysis against DDI 
water using Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at room temperature. 
The product was subsequently lyophilized and isolated as a white powder. 
1
H NMR 
spectroscopy see Figure 3.7. Isolated yield: 1.4 g. 
3.3.7 Preparation of polystyrene nanoparticles via emulsion polymerization.  
Batch emulsion polymerizations of styrene were all carried in a three-neck reactor equipped 
with a reflux condenser, nitrogen inlet and mechanical stirrer.  A typical reaction proceeded 
as follows: PS45-b-(PLGA31-r-GA35) (0.25 g) was added to the reactor under an inert 
atmosphere and dissolved in 34 mL of distilled water under stirring at 70 ºC. 4 mL of a 
sodium carbonate buffer solution (80 mg) was deoxygenated and injected into the reactor. 
The styrene monomer (4.80 g) was deoxygenated separately for 20 min by bubbling nitrogen 
through it and injected into the reactor. A deoxygenated initiator solution (50 mg of 
potassium persulfate in 2 mL of water) was injected to start the polymerization. The nitrogen 
flow was maintained throughout the reaction. Samples were withdrawn at regular times to 
determine the conversion. A small amount of hydroquinone was added to these aliquots to 
quench the radical polymerization where the monomer conversion was then determined via 
gravimetry. 
3.3.8 Nile Red encapsulated NPs.  
Nile Red (NR) was encapsulated in the polystyrene nanoparticles by dissolving NR (0.1 wt% 
with regard to monomer) in the styrene monomer and subsequently forming the particles via 
an emulsion polymerization (as previously described). 
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3.3.9 PS45-b-(PLL45-r-LA26-r-FITC2).  
Fluorescein isothiocyanate (FITC) was attached to the lysine residues at 1.5 molar 
equivalents per chain. FITC was dissolved in DMSO and added to PS45-b-(PLL47-r-LA28)75 
solubilized in PBS pH 7.2. The resulting polymer was purified via dialysis against DDI water 
using Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h and isolated as an orange 
powder.  
3.3.10 Lectin binding.  
The selective lectin-carbohydrate binding between the galactose moieties and RCA120 was 
done on a qualitative basis. After particle synthesis, the polystyrene latex was diluted with 
PBS buffer (pH 7.2) and a solution of the RCA120 lectin (1mg/mL) was added until the system 
collapsed. The reversibility of the system was indicated via the addition of dissolved 
lactobionic acid in PBS buffer.   
3.3.11 Cell binding.  
Chinese hamster ovary (CHO) cells were seeded at 2 x 10
5
 in 2 mL media on a 35 mm glass 
bottom culture dish for 24 h at 37ºC at 5% CO2. The media was removed and cells were 
washed with PBS (supplemented with 1.1mM MgCl2 and 0.9 mM CaCl2). The particles were 
added to the cells in phenol red-free media (1:4 dilution) and were incubated for 2 h at 37 ºC 
at 5% CO2 in the dark. Cells were washed with 1mM lactobionic acid in PBS for 15 minutes 
at 37 ºC to assess displacement of any bound particles. 
3.3.12 Methods. 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance 400 (400 
MHz) in DMSO-d6 and CDCl3 as solvents. All chemical shifts are reported in parts per 
million (ppm) with tetramethylsilane (TMS) as an internal reference. Size Exclusion 
Chromatography (SEC) was performed on an Agilent 1200 system in conjunction with two 
PSS GRAM analytical (8 x 300 and 8 x 100, 10 μ) columns, a Wyatt Dawn Heleos 8 multi 
angle light scattering (MALS) detector and Wyatt Optilab rEX differential refractive index 
(DRI) detector with a 658 nm light source. The eluent was DMF containing 0.1 M LiBr at a 
flow rate of 1 mL/min. The column temperature was set to 40 °C with the MALS detector at 
35 °C and the DRI detector at 40 °C. Molar masses and dispersities were calculated from the 
MALS signal by the Astra software (Wyatt) using the refractive index increment (dn/dc) as 
determined experimentally. The specific refractive index increments for the copolymers were 
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calculated relative to the ratio of the homopolymer. The dn/dc values used for PS, PZLL and 
PBLG were 0.159, 0.120 and 0.118 mL/g respectively. All samples for SEC analysis were 
filtered through a 0.45 mm PTFE filter (13 mm, PP housing, Whatman) prior to injection. 
Dynamic light scattering (DLS) experiments were performed at 25 °C on a Malvern NanoZS 
(Malvern Instruments, Malvern UK) which uses a detection angle of 173°, and a 3 mW He-
Ne laser operating at a wavelength of 633 nm. The hydrodynamic diameter and 
polydispersity index (PDI) values were obtained using cumulated analysis. Field emission 
scanning electron microscopy (FESEM) images were obtained on a Hitachi S5500 SEM. 
Cells were imaged using a Zeiss LSM510 Meta confocal microscope using a 63x oil 
immersion objective lens and heated stage set to 37 ºC. The particles were excited using 514 
nm laser, and the emission collected using a long pass 560 nm filter set. 
3.4 Results and Discussion        
3.4.1 Synthesis of glycosylated amphiphilic block copolymers. 
The synthesis of polypeptide-PS block copolymers was achieved following a strategy 
previously reported from our group by the macroinitiation of NCA ring-opening 
polymerization from amine-functional PS 2 obtained by reversible addition–fragmentation 
chain transfer (RAFT) polymerization (Scheme 3.1).
54
  
 
Briefly, a phthalimide protected amine is incorporated in a trithiocarbonate RAFT chain 
transfer agent (CTA, 1) which allows for effective control over the polymerization of 
styrenics. Tributyltin hydride in the presence of AIBN was used successfully to quantitatively 
remove the trithiocarbonate group.
54-56
 Quantitative deprotection of the phthalimide 
protecting group followed on treatment with excess hydrazine monohydrate (Scheme 3.1, 
Figure 3.2) resulting in the PS-NH2 macroinitiator 2 (4700 g/mol, Ɖ = 1.1).   
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Scheme 3. 1 Synthesis of glycosylated block copolymers
a
 
a
Reagents and conditions: (a) Bu3SnH (8 eq), AIBN (3 eq) THF, 60 °C; (b) NH2NH2 (20 eq), 
DMF, 70 °C; (c) BLG-NCA (70 [M]0/[MI]0), DMF, HV, 0 °C; (d) ZLL-NCA (70 
[M]0/[MI]0), DMF, HV, 0 °C; (e) HBr (33 wt. % in AcOH), TFA; 0.5 M NaOH (aq); (f) 
DMT-MM, DDI; (g) HBr (33 wt. % in AcOH), TFA; (h) LA, EDC/NHS, pH 4.7, 10 mM 
MES buffer; DDI. MI = macroinitiator, HV = high vacuum, DDI = distilled deionized water. 
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Figure 3.  2 
1
H-NMR spectra indicating selective deprotection of the α- and ω-end-
functional PS homopolymer (1). Cleavage of the trithiocarbonyl moeity (1B) with tributyltin 
hydride and subsequent hydrazinolysis of the pthtalimide protecting group leads to the amine 
end-functional PS homopolymer (2).  
The subsequent NCA polymerizations were run at 0 °C under high vacuum to combine high 
polymerization control with efficient removal of the reaction by-product CO2 to accelerate 
the polymerization rate.
57, 58 
The PS-NH2 macroinitiator was chain extended with ε-
benzyloxycarbonyl-L-lysine (ZLL) (Figure 3.3) and γ-benzyl-L-glutamate (BLG) NCAs 
where chain lengths of 70 repeat units were targeted (Scheme 3.1). Figure 3.4 shows the size 
exclusion chromatography (SEC) traces of the PS45-b-PBLG66 (3) and the PS macroinitiator 
(2). A shift in the elution time upon macroinitiation confirms the formation of the block 
copolymer with no residual homopolymer present highlighting efficient initiation.  
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Figure 3.  3 SEC traces of PS45-NH2 (2, black) and PS45-b-PZLL73 (4, red). 
 
 
 
Figure 3.  4 SEC traces of PS45-NH2 macroinitiator (2, black) and PS45-b-PBLG66 (3, red).  
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Table 3. 1 Characteristics of poly(styrene) macro-initiator (MI) and block copolymers. 
Polymer
(a)
 [NCA]0/[MI]0 Mw
(b)
 (g/mol) Ɖ 
PS45-NH2 (MI) (2) - 4800 1.1 
PS45-b-PZLL75 (4) 70 22 300 1.1 
PS45-b-PBLG66 (3) 70 18 200 1.1 
(a) Degree of polymerization was determined via 
1
H-NMR spectroscopy by calculating the 
ratio of styrene to polypeptide repeat units using the methylene protons of the polypeptide 
protecting group (5.0 ppm) to that of the combined signals of the aromatic protons of styrene 
and the polypeptide protecting group (6.2 – 7.5 ppm) (Figure S3). (b) Values obtained from 
multi angle light scattering (MALS) detection.  
Both block copolymers were further characterized using 
1
H-NMR, where comparison of the 
polypeptide protecting group signals with that of the characteristic aromatic polystyrene 
signals allowed determining the respective degrees of polymerization as summarized in Table 
3.1 (see Figure 3.5). For both block copolymers there is a good agreement between the 
monomer to macroinitiator feed ratio (70) and the calculated degree of polymerization (75 
and 66, respectively). 
 
Figure 3.  5 
1
H-NMR spectra (TFA-d, 400 MHz) of PS45-b-PZLL75 (4) and PS45-b-PBLG66 
(3) 
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After quantitative deprotection of the polypeptide block, galactose was covalently attached to 
the amino acid units via two different strategies targeting 35 % and 50 % glycosolation 
(Scheme 3.1) depending on the size of the sugar. A procedure described by Menzel et. al. was 
employed to attach D-galactosamine (GA) to the carboxylic acid moieties of the PS45-b-
PLGA66 to prepare PS45-b-(PLGA31-r-GA35)66 (5) (Figure 3.6).
44
 4-(4,6-Dimethoxy-1,3,5-
triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM) is a mild and efficient amide-
coupling agent, which was used to facilitate the reaction. DMT-MM allows for a high degree 
of substitution while it has been shown to be a very versatile component in preparing 
polyglutamic acid derivatives with orthogonal reactive sites.
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Figure 3.  6 
1
H-NMR spectra (D2O, 400 MHz) of PS45-b-PLGA66 (3, top) and PS45-b-
(PLGA31-r-GA35)66 (5, bottom). The * signals are due to the residual DMT-MM. 
For PS45-b-PLL75, EDC/NHS coupling chemistry was used to attach lactobionic acid (LA, 4-
O-β-galactopyranosyl-D-gluconic acid, 7) to the lysine residues typically targeting 35% 
glycosylation of the PLL block. LA is a readily available disaccharide with a galactose 
moiety and a cost effective alternative to the functional sugars typically incorporated in other 
glycosylation strategies. 
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Figure 3.  7 
1
H-NMR spectra (in D2O) of PS45-b-PLL75 (top) and PS45-b-(PLL46-r-LA28) 
(6) (bottom). 
Figure 3.7 shows the 
1
H-NMR spectra of the PS45-b-(PLL47-r-LA28)75 copolymer (6) and the 
corresponding precursor block copolymer. The success of the glycosylation is evident from 
the presence of characteristic LA signals between 3.5 and 4.6 ppm. 
3.4.2 Emulsion polymerization to obtain polystyrene nanoparticles 
Glycosylation of the polypeptide block permitted to impart certain traits necessary for the 
effective stabilization of the targeted polymer NPs. It was envisaged that by attaching highly 
water-soluble carbohydrate moieties the electrolytic nature of the polypeptide would 
decrease. At the same time, the effective range of macromolecular stabilization during the 
synthesis of the hydrophobic latex particles was expected to increase. To the best of our 
knowledge glycosylated polypeptide hybrid block copolymers have not yet been investigated 
in emulsion polymerization.  
The emulsion polymerization of styrene stabilized by either PS45-b-(PLGA31-r-GA35)66 (5) or 
PS45-b-(PLL47-r-LA28)75 (6) was carried out in order to evaluate the ability of the hybrid 
conjugates to form stable polystyrene nanoparticles with a brush-like periphery. All reactions 
were performed using potassium persulfate as a water-soluble initiator at 70 °C and a 
concentration of 1 wt% with respect to monomer (1 pphm). Monomer contents of 12 and 15 
wt%, and block copolymer contents of 2 and 5 pphm were used for both block copolymers. In 
 62 
 
all but one experiment high styrene conversion and stable particle dispersion were obtained.  
Only in the case of using a low concentration of PS45-b-(PLL47-r-LA28)75 (i.e., 2 pphm) a 
stable latex could not obtain, which implies that PS45-b-(PLGA31-r-GA35)66 has better 
stabilizing properties than PS45-b-(PLL47-r-LA28)75. Conversion-time curves for the PS45-b-
(PLGA31-r-GA35)66-stabilized emulsion polymerizations are shown in Figure 3.8. All three 
curves show the absence of a nucleation period typical for a conventional ab initio emulsion 
polymerization. This behavior, which we observed before, suggests that the block copolymer 
micelles present at the start of the reaction act as a seed and are converted into particles.60-63  
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Figure 3.  8 Evolution of monomer conversion with time for the emulsion polymerization 
of styrene using KPS as initiator (1 wt%), a monomer content of 12 wt% and surfactant 
content of 5 wt% (■), a monomer content of 15 wt% and surfactant content of 5 wt% (●),a 
monomer content of 15 wt% and surfactant content of 2 wt% (▲) with PS45-b-(PLGA31-r-
Gal35)  as stabilizer. 
Furthermore it is clear from this Figure that higher block copolymer concentrations lead to 
faster rates. This observation is consistent with the smaller particle diameters as determined 
using dynamic light scattering (Table 3.2) (Figure 3.9) for the higher block copolymer 
concentrations; smaller diameters imply larger particle numbers, which in turn lead to higher 
polymerization rates. The increase in monomer content while maintaining a constant 
surfactant/monomer ratio does not significantly affect either particle size (Table 3.2) or the 
polymerization rate (Figure 3.8), implying that in both cases very similar particles are 
produced, i.e., particles of the same size and same glycopolymer periphery. These results, in 
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combination with the narrow particle size distributions (PDI < 0.02, see Table 3.2), clearly 
demonstrate the high amount of control over particle synthesis with these block copolymer 
surfactants.  
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Figure 3.  9 Intensity particle size distribution (DLS) for the latex particles prepared with a 
monomer content of 12 wt% and surfactant content of 5 wt% (■), a monomer content of 15 
wt% and surfactant content of 5 wt% (●),a monomer content of 15 wt% and surfactant 
content of 2 wt% (▲) with PS45-b-(PLGA31-r-GA35)66 as stabilizer. 
In the case of PS45-b-(PLL47-r-LA28)75 6 as the macromolecular surfactant, it was found that 
the stabilization was not as effective as for PS45-b-(PLGA31-r-GA35)66 5; only at block 
copolymer contents of 5 pphm stable dispersions were obtained. Interestingly, at block 
copolymer contents of 5 pphm both block copolymers seem to be able to stabilize very 
similar particle surface areas as can be concluded from the similar particle diameters listed in 
Table 3.2 (Also see Figure 3.10 and Figure 3.11).  
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Figure 3.  10 Evolution of monomer conversion with time for the emulsion polymerization 
of styrene using KPS as initiator (1 wt%), a monomer content of 12 wt% and surfactant 
content of 5 wt% (●), a monomer content of 15 wt% and surfactant content of 5 wt% (■),a 
monomer content of 15 wt% and surfactant content of 2 wt% (▲) with PS45-b-(PLL47-r-
LA28)75 as stabilizer. 
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Figure 3.  11 . Intensity particle size distribution (DLS) for the latex particles prepared with 
a monomer content of 15wt% and surfactant content of 5 wt% (●), a monomer content of 12 
wt% and surfactant content of 5 wt% (■) with PS45-b-(PLL47-r-LA28)75 as stabilizer. 
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All particles were further investigated with FE-SEM highlighting the uniformity of the 
particles, all ranging between in 80 – 90 nm in diameter (Figure 3.9).     
Table 3. 2 Results from the emulsion polymerization of styrene using glycosylated block 
copolymers as surfactants 
block copolymer 
Solids content 
(Wt%)a 
[block copolymer] 
(pphm)b 
Dz (nm)
c PDId
 
PS45-b-(PLGA31-g-Gal35) 12 5 114 0.02 
PS45-b-(PLGA31-g-Gal35) 15 5 120 0.02 
PS45-b-(PLGA31-g-Gal35) 15 2 147 0.02 
PS45-b-(PLL47-g-LA28) 12 5 111 0.06 
PS45-b-(PLL47-g-LA28) 15 5 119 0.04 
PS45-b-(PLL47-g-LA28) 15 2 n/a n/a 
(a)
 solid content = mass polymer/mass dispersion. 
(b)
 1 pphm = 1 g block copolymer/100 g 
monomer. 
(c)
 Z-average particle diameter from Dynamic Light Scatering (DLS).                       
(d)
 Polydispersity Index of particle size distribution from cumulative DLS analysis. 
 
 
Figure 3.  12 FE-SEM images of polystyrene latex stabilized by PS45-b-(PLGA31-r-GA35)66 
(5) with a monomer content of 12 wt% and surfactant content of 5 wt% (Table 3.2). 
3.4.3 Biological screening  
Various methods are available to prepare functional polystyrene microspheres, where the 
most common method would arguably be to engineer functional layers on existing 
microspheres by post-modification.
64, 65
 Divinylbenzene (DVB) as well as ethylene glycol 
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dimethacrylate (EGDMA) are typically incorporated to crosslink the PS particle resulting in 
free vinyl groups at the surface. Surface modification using thiol–ene chemistry can then be 
utilized to introduce glyco-functionalities as was demonstrated on microspheres by Alvarez-
Paino et. al.
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The use of functional macromolecular surfactants during an emulsion polymerization of 
hydrophobic monomer allow for a straightforward strategy to functional polymer NPs. 
Furthermore, the introduction of fluorescent tags to track the polystyrene particles as they 
target specific biological entities can readily be achieved. This is demonstrated using two 
different strategies. In the first instance a highly hydrophobic dye, Nile Red was incorporated 
during the emulsion polymerization of styrene at 0.1 wt% with regards to the monomer. 
Figure 3.13A depicts the PS particles stabilized by PS45-b-(PLGA31-r-GA35)66 in water under 
UV light. Here the incorporation of NR is evident as well as the effective stabilization due to 
the glycosylated hydrophilic shell. After the addition of a galactose binding lectin, RCA120, 
the hydrophilic nature of the carbohydrates are nullified and effectively forces the whole 
system to collapse upon itself (Figure 3.13B). The effects are however reversible as the 
addition of excess lactobionic acid and thus competing galactose moieties allow the system to 
revert to the original stabilized state. The same was observed for the system incorporating 
PS45-b-(PLL47-r-LA28)75 (Figure 3.14). 
 
 
Figure 3.  13 Image of Nile Red encapsulated PS45-b-(PLGA31-r-GA35) stabilized PS NPs in 
water before (A) and after (B) the addition of the lectin RCA120. PS45-b-(PLL45-r-LA26-r-
FITC2) is represented by C. 
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In a second system, the excess lysine residues of PS45-b-(PLL47-r-LA28)75 was utilized to 
prepare fluorescein labeled PS particles. The reactivity of fluorescein isothiocyanate (FITC) 
towards primary amines are well known and thus the synthesis of PS45-b-(PLL45-r-LA28-r-
FITC2)75 is a facile approach to fluorescent PS particles. Subsequently, PS45-b-(PLL45-r-
LA28-r-FITC2)75 was used to stabilize the emulsion polymerization of styrene to produce 
fluorescent glycosylated PS particles (Figure 3.13C).  
 
Figure 3.  14 Comparison of PS latex stabilized by PS45-b-(PLL47-r-LA28)75 before (A) and 
after (B) the addition of lectin RCA120.  
These results demonstrate the feasibility of the proposed approach allowing two methods of 
labeling, i.e. in the NP core and the periphery by simple chemistry. While this was not further 
pursuit here, this would allow the introduction of two different labels for imaging. Such an 
approach is potentially of significant value in fluorescence sensing applications where two 
probes are used to permit referencing of the transduction signal by an analytically inert probe.  
Such an approach has been described for dye encapsulation, for example in silicate or 
polystyrene spheres but the advantage of this approach is that the probes are physically 
separated between core and shell of the nanoparticle, which can reduce potential probe cross 
talk.
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While lectin binding experiments provide a conceptual proof for selective binding, in vitro 
cellular binding of the nanoparticles was investigated in CHO cells.
67
Carbohydrate receptors 
such as lectins are prevalent on cell surfaces, and CHO-K1 was used in the present study 
because this cell line has been demonstrated previously to express relatively large amounts of 
Galectin 1, which resides at the plasma membrane and can bind to extracellular 
glycoconjugate ligands.
68, 69
 Figure 3.15 shows confocal images of live CHO cells following 
2 h incubation with 1:4 PS45-b-(PLGA31-r-GA35)66 (5) nanoparticles in cell media (A and B). 
It was found that the particles bound strongly to the cell surface, and remained bound after 
AA  B 
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washing several times with PBS (supplemented with 0.9 mM CaCl2 and 1.1 mM MgCl2). 
Using confocal imaging, scanning in the Z-direction, it was confirmed that the particles did 
not permeate the cells. 
To confirm surface binding was specific, lactobionic acid containing a galactose moiety was 
used in order to remove any specifically bound particles on the cell surface. This was 
achieved by incubating CHO cells with 1 mM lactobionic acid in PBS for 15 minutes at 37 
C. The media was removed from the cells and they were washed with PBS buffer 
(supplemented with 0.9 mM CaCl2 and 1.1 mM MgCl2). Figure 3.15C shows that particles 
were displaced by the wash step with lactobionic acid. 
To assess if the binding process to the cell surface could be blocked, CHO cells were 
incubated with 300 µM lactobionic acid in cell media for 1 h at 37 ºC and particles were 
added to give the final concentration (a 1 in 4 dilution) for a further 2 h. Figure 3.15D 
confirmed that the particles could not bind to the cell surface in the presence of lactobionic 
acid. It is important to note that in the control described above where the cells were washed 
extensively with PBS buffer in the absence of lactobionic acid, the particles remained bound 
to the cell surface, ie. they were not removed by washing. These results indicate that the 
galactose modified particles bound in a receptor specific way to the cell surface. 
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Figure 3.  15 Confocal fluorescence imaging showing binding of nanoparticles (1:4 
dilution) to live CHO cells following a 2 h incubation at 37 ºC (Fig 2A) where Fig 2B 
expands a single cell image to show the distribution of particles at the cell surface (z = 3.5). 
Figures 1A and 1B show the reflectance images of the cells superimposed on the fluorescence 
images. Fig 2C shows the fluorescence images of the CHO cells treated with the 
nanoparticles, after they had been washed with 1mM lactobionic acid in PBS for 15 minutes 
at 37 ºC, the absence of fluorescence confirmed binding was reversed. Fig 2D shows that 
following incubation with 300 µM lactobionic acid for 1 h, prior to the addition of 
nanoparticles (1:4 dilution) for 2 h, no particle binding occurred. Figures 1C and 1D show the 
reflectance images for these studies superimposed on the fluorescence images to confirm that 
the cells were present but unmodified by the particles.  
3.5 Conclusion     
Hybrid block copolymers consisting of poly(styrene) and a poly(amino acid) segments were 
synthesized via combination of RAFT and NCA polymerization. The polypeptide segments 
were glycosolated with galactose moieties using traditional coupling chemistry. The resulting 
amphiphilic block copolymers were found to be efficient stabilizers in the emulsion 
polymerization of styrene offering a facile method for the synthesis of fluorescent 
glycosylated polystyrene nanoparticles. The availability of the galactose units introduced 
through the glycopolymer surfactant at the nanoparticles surface for selective binding was 
successfully demonstrated by lectin binding experiments and binding to Chinese hamster 
ovary (CHO) cells. This approach provides a straightforward route to highly fluorescent 
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nanoparticles with selective binding properties for imaging applications avoiding particle 
post-modification. 
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Chapter 4 
Amphiphilic glycosylated block copolypeptides as macromolecular 
surfactants in the emulsion polymerization of styrene.   
 
 
 
 
 
 
 
 
 
 
 
This work was published in the journal Polymer Chemistry: 
Jacobs, J.; Gathergood, N.; Heuts, J. P. A.; Heise, A., Amphiphilic glycosylated block 
copolypeptides as macromolecular surfactants in the emulsion polymerization of styrene. 
Polymer Chemistry 2015, 6, (25), 4634-4640. 
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4.1  Abstract 
Diblock copolymers consisting of poly(L-phenyl alanine) and poly(benzyl-L-glutamate) or 
poly(CBZ-L-lysine), respectively, were synthesized via sequential NCA polymerization. 
After deprotection, subsequent partial glycosylation of the glutamic acid and lysine units with 
galactosamine hydrochloride or lactobionic acid yielded amphiphilic block copolypeptides. 
Moreover, a triblock copolymer poly(L-phenyl alanine-b-L-benzyl glutamate-b-
propargylglycine) was obtained and glycosylated by ‘click’ chemistry. Glycosylated block 
copolypeptides showed improved water solubility and circular dichroism (CD) confirmed the 
pH dependence of the helix-coil transition. The block copolypeptides were found to be 
efficient stabilizers in the emulsion polymerization of styrene offering a facile method for the 
synthesis of polystyrene nanoparticles in the range of 100-140 nm depending on the block 
copolymer composition and emulsion concentration. This establishes an example of 
functional polymer additives fully based on renewable building blocks in nanomaterial 
synthesis.  
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4.2  Introduction  
Over the last decade significant efforts have been made to introduce green approaches in 
polymer science. Prominent examples include polymers from renewable raw materials and 
bio-based feedstock.
1-3
 Notably most of these renewable polymers are polycondensates and 
some of these materials have shown academic and industrial merit.
4-7
 Another important class 
of monomers are acrylates and the corresponding polyacrylates are very versatile and 
adoptable to a range of applications due to their side chain functionality. A class of 
monomers similar in functionality yet fully bio-based is amino acids. Although it cannot be 
expected that poly(amino acids) can be a broad substitute for polyacrylics, they might be an 
alternative in some segments. 
Significant advances in the controlled ring-opening polymerisation of amino acid N-
carboxyanhydrides (NCA)
8, 9
 has fuelled opportunities for the design of well-defined 
macromolecular structures such as block
9-11
, graft
12
, star (co)polymers
13-16
, polymer 
brushes
17-19
, etc., which shows parallels to the development in controlled radical 
polymerisation. While most authors propose such structures in the wider context of 
biomedical applications, we believe that there is scope in exploring poly(amino acid)s or 
synthetic polypeptides in non-medical applications. One such area is surface-active 
amphiphilic block copolymers as surfactants or emulsifiers. A few examples of amphiphilic 
block copolypeptides have been reported primarily with the aim to study their self-
organisation into micelles and vesicles.
20-22
 The use of polypeptides as macromolecular 
emulsifiers is largely unexplored despite the fact that proteins are the stabilizers in natural 
rubber latex.
23
 Reported examples are generally limited to lower molecular weight 
analogues.
24-28
 Only recently Deming has shown that it was possible to stabilize water-in-oil-
in-water double emulsions using racemic amphiphilic copolypeptides prepared via NCA 
polymerisation.
29
 Here we report glycosylated polypeptide block copolymers as efficient 
surfactants in emulsion polymerisation. This process was selected as it will provide not only 
information about the initial stability of an emulsion but also the ability of the amphiphilic 
block copolypeptides to provide emulsion stability throughout the demanding process of latex 
formation.  
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Scheme 4.1 Reagents and conditions: (a) BLG-NCA ([M]0/[I]0 = 60); PA NCA DMF 
([M]0/[I]0 = 20), HV, 0 °C; (b) HBr (33 wt. % in AcOH), TFA; 0.5 M NaOH (aq); (c) 
GA.HCl, DMT-MM, DDI (d) ZLL-NCA ([M]0/[I]0 = 60); PA NCA DMF ([M]0/[I]0 = 20), 
HV, 0 °C (e) HBr (33 wt. % in AcOH), TFA; (f) LA, EDC/NHS, pH 4.7, 10 mM MES 
buffer; DDI (g) PGL NCA ([M]0/[I]0 = 7); BLG-NCA ([M]0/[I]0 = 60); PA NCA DMF 
([M]0/[I]0 = 20), HV, 0 °C; (h) GalAc, Cu(PPh3)3Br, Et3N, DMF, 30 °C; (i) HBr (33 wt. % 
in AcOH), TFA. I = allylamine, HV = high vacuum, DDI = distilled deionized water. 
4.3  EXPERIMENTAL  
4.3.1 Materials  
All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. γ-Benzyl-L-glutamate and ε-benzyloxycarbonyl-L-lysine were supplied by Bachem. 
Anhydrous DMF, chloroform, ethyl acetate, methanol were used directly from the bottle 
under an inert and dry atmosphere. γ-Benzyl-L-glutamate (BLG), ε-benzyloxycarbonyl-L-
lysine (ZLL), Phenyl alanine (PA) and DL-propargylglycine (PGL) NCA was synthesised 
following literature procedures.
21, 30, 31
 1-β-Azido-2,3,4,6-tetraacetyl-D-galactose (GalAc) 
was synthesized following a literature procedure.
32
 
 79 
 
4.3.2 Preparation of copolypeptides PBLG60-b-PPA20 (1).  
The NCA monomer of BLG (2.5 g, 9.5 mmol) was dissolved in 20 mL anhydrous DMF in a 
Schlenk tube. The solution was degassed via three successive freeze-pump-thaw cycles and 
kept under vacuum. The reaction flask was immersed in a 0 °C water bath and a solution of 
12 μL allylamine in 1 mL anhydrous DMF ([M]0/[I]0 = 60) was injected through a rubber 
septum with a syringe. The reaction was left to stir until the BLG NCA had been completely 
consumed as monitored by ATR-FTIR spectroscopy. The polypeptide was further chain 
extended via the introduction of phenyl alanine NCA (0.60 g, 3.1 mmol, [M]0/[I]0 = 20) 
dissolved in 5 mL DMF. After full monomer conversion monitored via ATR FTIR 
spectroscopy the polymer was precipitated into an excess of diethyl ether, filtered and dried 
under vacuum. Isolated yield: 2.2 g.  
Similar procedures were used to synthesize PZLL59-b-PPA24 (3) and PGL7-b-PBLG56-b-
PPA19 (5). 
4.3.3 Block copolypeptide deprotection.  
A general procedure was used for the deprotection of both the PBLG and PZLL pendant 
groups. PBLG60-b-PPA20 (2.0 g, 0.13
 
mmol) was dissolved in trifluoroacetic acid (20 mL). 4 
mL of HBr solution (33 wt.% in acetic acid; 3-fold excess with respect to γ-benzyl-L-
glutamate repeat units) was added slowly to the reaction at 0 °C. After 2 h, the solution was 
added to 300 mL diethyl ether and the precipitate washed three times with 50 mL diethyl 
ether. The subsequent product was dissolved in a 0.5M NaOH solution (aqua) to obtain the 
polymer in the sodium salt form. The sodium salt polymer was dialyzed against double 
deionized (DDI) water using Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at 
room temperature. The product PLGA60-b-PPA20 was lyophilized and isolated as a white 
powder. Isolated yield: 1.4 g.  
PZLL59-b-PPA24 was deprotected in a similar fashion to yield PLL59-b-PPA24.  
4.3.4 Glycosylation reactions 
4.3.4.1  (GA28-r-PLGA32)-b-PPA20 (2) 
Glycosylation of the carboxylic acid moieties was achieved according to a modified literature 
procedure.
33
 PLGA60-b-PPA20 (1.3 g, 0.12
 
mmol)  and galactosamine hydrochloride 
(GA.HCl) (0.79 g, 3.7 mmol, 0.5 eq w.r.t. the glutamate repeating units) was dissolved in 
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deionized water (10 mL) and stirred for 15 min. 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMT-MM) (1.2 g, 4.4 mmol, 1.2 eq. to Galactosamine HCl) 
was dissolved in 5 mL of deionized water and added to the reaction mixture. After stirring for 
24 h at room temperature 2 mL of a 1M NaOH aqueous solution was added to the reaction 
mixture and stirred for 3 hours. The mixture was then dialyzed against DDI water using 
Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at room temperature. The 
polymer was lyophilized and isolated as a white powder. Isolated yield: 1.7 g. 
4.3.4.2  (LA17-r-PLL42)-b-PPA24 (4)  
A general procedure for 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC)/N-hydroxysulfosuccinimide (Sulfo-NHS) coupling was employed to 
attach lactobionic acid to the lysine residues of the amphiphilic copolypeptide. Lactobionic 
acid (LA) (0.7 g, 2 mmol, 0.3 eq w.r.t lysine repeat units), EDC (0.45 g, 2.3 mmol, 1.2 eq 
w.r.t. the LA) and sulfo-NHS (50 mg, 0.23 mmol, 0.1 eq w.r.t. EDC) were dissolved in 3 mL 
10 mM MES buffer (pH 4.7) and stirred for 20 minutes. The latter was added to a solution of 
PLL59-b-PPA24 (1.2 g, 0.11
 
mol) in 10 mL of DDI water. The reaction mixture was stirred 
overnight. The resulting product was purified via dialysis against DDI water using 
Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at room temperature. The 
product was subsequently lyophilized and isolated as a white powder. Isolated yield: 1.5 g. 
4.3.4.3  GA7-b-PBLG56-b-PPA19 (6) 
Glycosylation was achieved via a modified procedure previously utilized in our group.
21
 
PGL7-b-PBLG56-b-PPA19 (1.5 g, 0.66 mmol of alkyne units), 1-β-Azido-2,3,4,6-tetraacetyl-
D-galactose 0.3 g, 0.8 mmol, 1.2 eq. to alkyne groups) and triethylamine (40 μL, 0.5 eq.) was 
dissolved in 20 mL of anhydrous DMF in a Schlenk tube. The mixture was stirred and 
degassed by bubbling nitrogen for 30 min. (PPh3)3CuBr (60 mg, 0.1 eq.) was then added and 
nitrogen was bubbled through the resulting solution for another 30 min. The Schlenk tube 
was placed in an oil bath at 30 °C for 24 h under nitrogen atmosphere. 100 mg of Amberlite® 
IR120 hydrogen form ion exchange resin was added and the suspension gently stirred at 
ambient temperature overnight. After filtration and centrifugation, the polymer solution was 
precipitated in a 3:2 THF/diethyl ether mixture and washed with THF. Isolated yield:  1.6 g. 
Subsequent deprotection as described above results in the simultaneous deprotection of the 
benzyl ester and tetraacetate groups to yield GA7-b-PLGA56-b-PPA19. 
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4.3.5 Preparation of polystyrene latex via emulsion polymerization.  
Styrene was polymerized using a similar method described previously.
34
 Batch emulsion 
polymerizations were all carried out in a three-neck reactor equipped with a reflux condenser, 
nitrogen inlet and mechanical stirrer.  A typical reaction proceeded as follows: GA28-r-
PLGA32-b-PPA20 (0.24 g) was added to the reactor under an inert atmosphere and dissolved 
in 38 mL of distilled water under stirring at 70 °C. The styrene monomer (4.8 g) was 
deoxygenated separately for 20 min by bubbling nitrogen through it and injected into the 
reactor. A deoxygenated initiator solution (50 mg of potassium persulfate in 2 mL of water) 
was injected to start the polymerization. The nitrogen flow was maintained throughout the 
reaction. Samples were withdrawn at regular times to determine the conversion. A small 
amount of hydroquinone was added to these aliquots to quench the radical polymerization 
where the monomer conversion was then determined gravimetrically. 
4.3.6 Methods.  
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance 400 (400 
MHz) in DMSO-d6 and CDCl3 as solvents. All chemical shifts are reported in parts per 
million (ppm) with tetramethylsilane (TMS) as an internal reference. Attenuated Total 
Reflection (ATR) FTIR measurements were performed on a Perkin-Elmer Spectrum 100 
instrument. Spectra were obtained from 4 scans with a resolution of 2 cm
-1
 in the spectral 
region of 650 – 4000 cm-1. A background measurement was taken before the sample was 
loaded onto the ATR for measurement. Samples could be characterized in the liquid state 
without prior sample preparation. Size Exclusion Chromatography (SEC) was performed on 
an Agilent 1200 system in conjunction with two PSS GRAM analytical (8 x 300 and 8 x 100, 
10 μ) columns, a Wyatt Dawn Heleos 8 multi angle light scattering (MALS) detector and 
Wyatt Optilab rEX differential refractive index (DRI) detector with a 658 nm light source. 
The eluent was DMF containing 0.1 M LiBr at a flow rate of 1 mL/min. The column 
temperature was set to 40 °C with the MALS detector at 35 °C and the DRI detector at 40 °C. 
Molar masses and dispersities were calculated from the MALS signal by the Astra software 
(Wyatt) using the refractive index increment (dn/dc) as calculated relative to the ratio of the 
homopolymer. The dn/dc values used for the polymers were experimentally determined or as 
found in literature.
9, 35
 All samples for SEC analysis were filtered through a 0.45 mm PTFE 
filter (13 mm, PP housing, Whatman) prior to injection. Dynamic light scattering (DLS) 
experiments were performed at 25°C on a Malvern NanoZS (Malvern Instruments, Malvern 
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UK) which uses a detection angle of 173°, and a 3 mW He-Ne laser operating at a 
wavelength of 633 nm. Field emission scanning electron microscopy (FESEM) images were 
obtained on a Hitachi S5500 scanning electron microscope. CD spectra were recorded on a 
Jasco J-715 spectropolarimeter at ambient temperature. A quartz cell with 0.1 cm path length 
was used. Spectra were recorded between 250 and 190 nm. Each spectrum represents the 
average of five measurements. A baseline was taken from the pure solvent and subtracted 
from the spectra. The spectra were smoothed using a Savitzky–Golay smoothing filter. For 
the pH-dependent measurements, a stock solution of the copolypeptide (c.a. 0.3 mg/mL) in 
0.01 M NaCl solution was titrated with aqueous HCl or aqueous NaOH. Mean residue 
ellipticities were calculated using the equation [Θ]MRW = (ΘMRW)/(10 x c x l) with 
experimental ellipticity Θ in mdeg, mean residue weight MMRW in g/mol, mass concentration 
c  in mg/mL and path length l in cm.
36
 Helicities fα were calculated from the mean residue 
ellipticities at λ = 222 nm using the following equation:  (1). 
4.4  Results and discussion 
4.4.1 Synthesis of glycosylated block copolypeptides 
With the increasing interest in functional polymer nanoparticles, various strategies are 
available for preparing polymer colloids via block copolymer-stabilized emulsion 
polymerisation.
37-39
 Previously we demonstrated that hybrid amphiphilic block copolymers 
comprising a hydrophilic glycosylated polypeptide block and a hydrophobic polystyrene 
block could efficiently stabilise styrene latex formation.
34
 Using a polystyrene block, high 
compatibility with the styrene latex was achieved. For the purpose of utilizing polypeptide 
block copolymers as macromolecular stabilisers in this process, it was necessary to carefully 
select the hydrophobic polypeptide block. In order to obtain uniform polystyrene latex 
nanoparticles it is critically important that the hydrophobic block remains embedded in the 
latex particle throughout the polymerisation process.
40
 Phenyl-L-alanine (PA) was chosen as 
the amino acid for this block due to the structural resemblance of the phenyl substituent with 
styrene. 
Initially, two different diblock copolymers were synthesised by sequential NCA 
polymerisation from poly(benzyl-L-glutamate) (PBLG) and poly(Z-L-lysine) (PZLL), 
respectively (Scheme 4.1), i.e. PBLG60-b-PPA20 (1) and PZLL59-b-PPA24 (3) in DMF at 0 °C 
under vacuum using allylamine as an initiator.
11
 Due to the insolubility of PPA in DMF it 
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was necessary to first prepare the PBLG or PZLL block to prevent precipitation. The 
monomer conversion was followed by ATR-FTIR and the PA-NCA was added after 
complete disappearance of the initial NCAs anhydride peaks (1850 and 1790 cm
-1
). An 
increase in molecular weight as well as narrow, monomodal distributions are evident from the 
SEC traces (Figure 4.1 and 4.2; Table 4.1) highlighting the successful synthesis of the block 
copolymers. Notably, the synthesis of these amphiphilic block copolypeptides is more 
straightforward than the previously reported synthesis of amphiphilic hybrid block 
copolymers
34
. 
18 20 22 24
Elution Volume (mL)
 
Figure 4. 1 SEC traces of PBLG60 (red) and PBLG60-b-PPA20 (2, black) 
16 18 20 22 24
Elution Volume (mL)
 
Figure 4. 2 SEC traces of PZLL59 (black) and PZLL59-b-PPA24 (1, red). 
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To enhance amphiphilicity, the deprotected poly(L-glutamic acid) (PGA) and poly(L-lysine) 
(PLL) blocks were glycosylated using previously reported strategies.
33, 34
 The lysine residues 
of PLL59-b-PPA24 were coupled with lactobionic acid (LA) using traditional EDC/NHS 
coupling chemistry (Scheme 4.1) targeting 30% glycosylation (LA17-r-PLL42-b-PPA24, 4). 
The carboxylic acid residues of PLGA60-b-PPA20 were converted to the sodium salt form and 
galactosamine hydrochloride attached using an aqueous amide coupling approach in the 
presence of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-
MM) (Scheme 1) targeting 50% glycosylation (GA28-r-PLGA32-b-PPA20, 2). 
1
H-NMR 
spectra confirm the successful deprotection as well as the glycosylation for both polymers 
(Figures 4.3 and 4.4). 
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Figure 4. 3 
1
H-NMR spectra (D2O, 400 MHz) of LA17-r-PLL42-b-PPA24 (4). 
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Figure 4. 4 
1
H-NMR spectra (D2O, 400 MHz) of GA28-r-PLGA32-b-PPA20 (2). 
To further illustrate the versatility of the system a triblock copolymer PGL7-b-PBLG56-b-
PPA19 (Scheme 1, 5) was synthesised by sequential NCA polymerisation. Glycosylation was 
achieved by click chemistry of GA-azide with the alkyne groups of the propargylglycine 
block to yield GA7-b-PLGA56-b-PPA19 (6).
41
 While the total composition of this triblock 
copolypeptide is similar to 2, the amphiphilic block is arranged in a block rather than a 
random fashion. SEC and 
1
H-NMR analysis confirm the well-defined block structure and 
efficient glycosylation (Figures 4.5 and 4.6).  
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Figure 4. 5 SEC traces of PGL7-b-PBLG56 (black), PArg7-b-PBLG56-b-PPA19 (5, red) and 
GalAc7-b-PBLG60-b-PPA19 (blue). 
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Figure 4. 6 
1
H-NMR spectra (TFA-d, 400 MHz) of PGL7-b-PBLG56-b-PPA19 (3, black) 
and GalAc7-b-PBLG56-b-PPA19 (5, red). The * signals are due to DMF. 
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Table 4. 1 Polypeptide block copolypeptides 
Polymer
(a)
 [I]0/[M1]0/[M2]0 Mw
(b)
 (g/mol) Ɖ 
PBLG60-b-PPA20  1:60:20 16600 1.07 
PZLL59-b-PPA24  1:60:20 20400 1.07 
PGL7-b-PBLG56-b-PPA19  1:7:60:20 17500 1.09 
    aDegree of polymerization was determined by 1H-NMR spectroscopy (TFA-d) by calculating 
the ratio of the methine proton of the initiator allylamine (5.6 ppm) to the methylene protons 
of the polypeptide protecting group for PBLG/PZLL (4.9 – 5.2 ppm) and methylene group of 
PPA (2.7 – 3.0 ppm). bValues obtained from multi angle light scattering (MALS) detection. 
4.4.2 Solution properties of glycopolypeptides 
Ionic surfactants such as the block copolypeptides presented here are sensitive to solution pH. 
pH may directly impact the solubility and, unlike conventional surfactants, the secondary 
structure of the glycopolypeptides. The latter was investigated in aqueous solution by circular 
dichroism (CD) before and after glycosylation. CD measurements of the glycosylated and 
native block copolypeptides where compared at different pH values to establish the onset of 
secondary conformations. Figure 4.7 and A1 (see Appendix A) shows the CD spectra of 
PLGA60-b-PPA20 and (GA28-r-PLGA32)-b-PPA20 respectively. When lowering the pH a 
transition from a random coil, as evident from a negative Cotton effect with a minimum at ca. 
λ = 198 nm, to an α-helix at pH 6.32 is apparent from the two minima at λ = 208 nm and 222 
nm.
42
 The transition seems to be solely between random-coil and α-helices as indicated by an 
isodichroistic point occurring at λ = 204 nm.43 The native copolypeptide shows a maximum 
helicity of 35 % near pH 4 after which it precipitates from the solution, as the carboxylic 
moieties are being protonated.  
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Figure 4. 7   CD spectra of aqueous solutions of PLGA60-b-PPA20 as a function of pH 
The CD spectra of the glycosylated (GA28-r-PLGA32)-b-PPA20 replicate this trend except for 
some residual helical conformation still being present at pH 7.10. Glycosylation improves the 
solubility of the block copolypeptide down to pH 3 with a maximum helicity of 44 %. CD 
measurements of the triblock copolypeptides PGL7-b-PLGA56-b-PPA19 and GA7-b-PLGA56-
b-PPA19 as shown in Figures A2 and A3 display very similar trends before and after 
glycosylation. Both materials have the sole transition between a random coil and α-helical 
conformation as indicated by the isodichroistic point at λ = 204 nm. The onset of the 
transition is in the region of pH 6 irrespective of glycosylation. Furthermore, improved 
solubility upon glycosylation at lower pH was noticed. 
In the case of PLL block copolypeptides, it is known that the PLL block adopts a random coil 
conformation at low pH while assuming an α-helical conformation at higher pH as the amino 
groups get deprotonated.
44
 CD spectra of PLL59-b-PPA24 and (LA17-r-PLL42)-b-PPA24 (Figure 
A4 and A5) show exactly this where a transition from random-coil to the α-helical 
conformation can be seen as indicated by the two minima at λ = 208 nm and 222 nm. Figure 
4.8 indicates the calculated helicities for the respective native and glycosylated block 
copolypeptides. 
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The helicities were only calculated where no precipitation was evident. The increased 
solubility over the pH range as a whole is evident for the glycosylated copolypeptides.  The 
inherent electrolytic nature of the two respective amphiphiles means that solubility issues 
occur at the high and low pH limits, something seemingly well counteracted with the 
attachment of the carbohydrate moieties.  
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Figure 4. 8 Helicities determined for the block copolypeptides PLGA60-b-PPA20 (●), 
GA28-r-PLGA32-b-PPA20 (■), PLL59-b-PPA24 () and LA17-r-PLL42-b-PPA24 () as a 
function of pH. The arrows indicate the solubility range of the block copolypeptides. 
A similar trend was observed for the PGL7-b-PLGA56-b-PPA19 and GA7-b-PLGA56-b-PPA19, 
where the introduction of only 7 repeat units has a clear influence of the solubility below pH 
4 (Figure 4.9). 
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Figure 4. 9  Estimated helicities determined for the native copolypeptide, PArg7-b-
PBLG56-b-PPA19 (●) and its glycosylated counterpart, Gal7-b-PLGA56-b-PPA19 (■) as a 
function of pH. 
4.4.3 Emulsion Polymerisation 
To the best of our knowledge, the stabilization of synthetic latexes by an amphiphilic 
polypeptide has not been shown yet. For this purpose, the three copolypeptides, GA28-r-
PLGA32-b-PPA20, GA28-r-PLGA32-b-PPA20 and LA17-r-PLL42-b-PPA24 where utilized as 
fully amino acid and carbohydrate based macromolecular surfactants in the aqueous emulsion 
polymerization of styrene. All reactions were performed at 70 °C and initiated via the water-
soluble initiator potassium persulfate (KPS) at a concentration of 1 wt% with regard to 
monomer (1 pphm). Monomer contents of 12 and 15 wt%, and block copolymer contents of 2 
and 5 wt% with regard to monomer were used. Under the applied conditions the hydrophilic 
blocks were in a random coil conformation. It was found that all block copolypeptides could 
readily stabilize the formed polystyrene particles and only in the case where a low 
concentration of LA17-r-PLL42-b-PPA24 was used (2 pphm) no stable latex was obtained. This 
implies that the hydrophilic PLGA blocks result in better stabilization, a result we have 
observed before.
34 
 
 Conversion-time curves for the emulsion polymerization of styrene stabilized by GA28-r-
PLGA32-b-PPA20 are shown in Figure 4.10. The results (especially at higher stabilizer 
concentrations) show very short nucleation periods (if any), which suggests that preformed 
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block copolymer micelles act as seeds for the polymerisation.  Furthermore, the results in this 
figure show an increase in the polymerization rate as the copolypeptide concentration is 
increased. This result is expected as increasing block copolypeptide concentrations lead to 
higher particle numbers (Np), which in turn lead to a higher rates of polymerization, Rp (Rp  
Np).
45
 This argument is supported by the dynamic light scattering (DLS) results shown in 
Table 4.2, where it is clearly seen that increasing the copolypeptide concentration leads to a 
decrease in particle diameter. 
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Figure 4. 10 Evolution of monomer conversion with time for the emulsion polymerization 
of styrene using KPS as initiator (1 wt%) with GA28-r-PLGA32-b-PPA20 as stabilizer. 
Monomer content of 12 wt% and surfactant content of 5 wt% (■), monomer content of 15 
wt% and surfactant content of 5 wt% (●), monomer content of 15 wt% and surfactant content 
of 2 wt% (▲). 
The triblock, GA7-b-PLGA56-b-PPA19, acted as an effective stabilizer in the emulsion 
polymerization of styrene. Figure 4.11 shows the conversion-time curves at varying monomer 
and copolypeptide wt% content and it is evident that no real differentiation can be made 
regarding the polymerization rates of any of the three curves. Once again DLS showed no 
significant difference in particle size at increasing monomer content and constant 
copolypeptides/monomer ratio. A sharp increase in size to 120 nm is however evident after 
decreasing the copolypeptides content to 2 pphm, as fewer and thus larger particles are 
prepared (Table 2). 
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Figure 4. 11  Evolution of monomer conversion with time for the emulsion polymerization 
of styrene using KPS as initiator (1 wt%), a monomer content of 12 wt% and surfactant 
content of 5 wt% (■), a monomer content of 15 wt% and surfactant content of 5 wt% (●),a 
monomer content of 15 wt% and surfactant content of 2 wt% (▲) with GA7-b-PLGA56-b-
PPA19 as stabilizer. 
LA17-r-PLL42-b-PPA24 was not as effective in stabilizing the polystyrene nanoparticles as its 
glutamic acid counterparts (Figure 4.12). At low copolypeptide/monomer content (i.e. 2 
pphm) it was not possible to prepare a stable latex. At copolypeptides contents of 5 pphm it 
was however possible to form stable dispersions where the reaction kinetics are very similar 
to that of GA28-r-PLGA32-b-PPA20. Furthermore, DLS determined the particle sizes to be 
similar to that stabilized by GA28-r-PLGA32-b-PPA20, concluding that we have comparable 
particles which in ionic form will be of opposite charge.  
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Figure 4. 12 Evolution of monomer conversion with time for the emulsion polymerization 
of styrene using KPS as initiator (1 wt%), a monomer content of 12 wt% and surfactant 
content of 5 wt% (■), a monomer content of 15 wt% and surfactant content of 5 wt% (●), a 
monomer content of 15 wt% and surfactant content of 2 wt% (▲) with LA17-r-PLL42-b-
PPA24 as stabilizer. 
All particles were further investigated by FE-SEM. The images illustrate the uniformity of 
the particles in agreement with the low PDIs obtained from DLS (Figure 4.13). Particles sizes 
(80-100 nm) agree well with sizes obtained by DLS considering the non-hydrated state of the 
particles surfactant layer in SEM. 
 
 
Figure 4. 13 FE-SEM images of polystyrene latex stabilized by GA28-r-PLGA32-b-PPA20 
(3) with a monomer content of 12 wt% and surfactant content of 5 wt% (Table 4.2). 
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Table 4. 2 Results from the emulsion polymerization of styrene using glycosylated block 
copolymers as surfactants. 
Polymer 
monomer 
content
(a)
 
(Wt%) 
[polymer]
(b)
 
(pphm) 
Dz
(c)
 
(nm) 
PDI
(d)
 
GA28-r-PLGA32-b-PPA20 12 5 114 0.08 
GA28-r-PLGA32-b-PPA20 15 5 118 0.09 
GA28-r-PLGA32)b-PPA20 15 2 140 0.03 
GA7-b-PLGA56-b-PPA19 12 5 98 0.03 
GA7-b-PLGA56-b-PPA19 15 5 106 0.05 
GA7-b-PLGA56-b-PPA19 15 2 120 0.05 
LA17-r-PLL42-b-PPA24 12 5 112 0.02 
LA17-r-PLL42-b-PPA24 15 5 115 0.02 
LA17-r-PLL42-b-PPA24 15 2 n.a. n.a. 
(a) solid content = mass polymer/mass dispersion. (b) 1 pphm = 1 g block copolymer/100 g 
monomer. (c) Z-average particle diameter from Dynamic Light Scatering (DLS). (d) 
Polydispersity Index of particle size distribution from cumulants DLS analysis. 
 
 
 
 
 95 
 
4.5  Conclusions 
Block copolymers consisting of poly(L-phenyl alanine) and partially glycosylated poly(L-
glutamic acid) and poly(L-lysine), respectively, were synthesized via sequential NCA 
polymerization and subsequent polymer glycosylation. The resulting amphiphilic block 
copolypeptides were found to be efficient stabilizers in the emulsion polymerization of 
styrene offering a facile method for the synthesis of polystyrene nanoparticles. This signifies 
an example of functional polymer additives fully based on renewable building blocks in 
materials applications. 
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Chapter 5 
Core cross-linked polypeptide nanoparticles through the miniemulsion 
polymerization of UV responsive NCAs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work has been done in collaboration with Dr J.P.A. Heuts and M. Moradi from 
Eindhoven University of Technology (TU/e), The Netherlands. 
100 
 
5.1 Introduction 
The design of smart carriers in the sub-micron range allows for unique characteristics which 
lead to changes in the mechanical, electrical and optical properties of materials. This 
evolution of controlled design has touted nanotechnology as the next revolution in many 
industries including agriculture, food industry, cosmetics and medicine.
1-6
 
Nanoparticle delivery systems with the ability to encapsulate and controllably release 
bioactive compounds is a sought after trait that has received increased interest due to the 
broad range of possible applications. One such application area is in the (site-specific) 
delivery of active pharmaceutical ingredients such as vaccines, genes, drugs and other 
biomolecules in the (bio)medical field.
7-9
 Currently, polymeric nanoparticles based on natural 
polymers such as chitosan or gelatine, or aliphatic polyesters such as poly(glycolic acid) 
(PGA) and poly(lactic acid) (PLA) as well as their copolymers i.e., poly(D,L-lactide-
coglycolide) (PLGA) are the most widely utilized drug delivery systems.
7, 10-12
 Both natural 
polymers and PLGA have advantages and drawbacks, which makes them more or less suited 
for certain application areas. For example, natural polymers usually have a good 
biocompatibility. However, obtaining reproducible sample quality from natural sources can 
be challenging. PLGA can be produced reproducibly but is hydrophobic in nature, which 
makes loading of hydrophilic drugs challenging.
13, 14
  
For a product to be applicable in nano-particular drug delivery it is necessary to conform to a 
number of requirements. Generally these materials should be biocompatible, have a tuneable 
degradation profile, produce only harmless degradation products, allow encapsulation of 
active ingredients and involve a scalable process that does not require harsh processing 
conditions, while maintaining a high long-term colloidal stability. Also desirable is the 
availability of functional groups that allow the surface modification for example to enhance 
circulation half-life (e.g. through PEGylation) or attachment of active/targeting biomolecules 
such as proteins, glycans or antibodies (specifically for pharmaceutical applications).
7, 9, 15-17
 
It is within these boundaries that polypeptides could play such a vital role. Over the last 
number of years researchers have developed functional materials based on amino acids by a 
technique called N-carboxyanhydride (NCA) ring-opening polymerisation (ROP).  In this 
process amino acids are converted into a reactive NCA, which can then be polymerised in a 
ring-opening polymerisation to yield synthetic polypeptides.
18
 This technique permits the 
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synthesis of functional polypeptides with controlled molecular weight, molecular architecture 
and composition.
19, 20 
Studies have shown that synthetic polypeptides from NCA polymerisation are versatile 
materials for the loading and release of small drugs and genetic therapeutics, respectively.
21, 
22
 For example, star shaped polypeptides with improved siRNA and pDNA loading, cargo 
protection and transfection characteristics were reported.
23-26
 Moreover, the functionalities of 
the amino acids building blocks (e.g. amines and carboxylic acid moieties) allow for facile 
chemical modification and bioconjugation of the polypeptides.
27
 Suitably, polypeptides are 
emerging as perfect candidates in therapeutic platforms and hold high potential as next 
generation biodegradable nanoparticles if a suitable processing methodology could be 
developed. 
28
 
Several strategies are available towards functional biodegradable nanoparticles. This would 
typically be dependent on the type of material used which varies from proteins, 
polysaccharides and biodegradable synthetic polymers. The protocols for nanoparticle 
preparation of these materials include the dispersion of preformed polymers, polymerization 
of monomer and ionic gelation methods.
29
 Nanoparticles derived from PGA, PLA, PLGA, 
poly-cyanoacrylate (PCA) and polycaprolactone (PCL) are all typically prepared by the 
dispersion of preformed polymers. This can be achieved in several ways such as solvent 
evaporation, solvent displacement, nanoprecipitation and salting out.
30-32
 
NPs that are prepared from monomers are polymerized to form in aqueous solution and this 
has been reported for the synthesis of PCA type NPs.
33, 34
 This method of preparation would 
typically involve mini-, micro-, and emulsion polymerization techniques resulting in 
nanoparticles, nanospheres or nanocapsules.
6, 35
 In brief, the synthesis is carried out in water 
using only the monomer, initiator and surfactant molecules. The active component can be 
dissolved or dispersed in the monomer solution followed by emulsification of the mixture to 
form an oil/water (o/w) emulsion using appropriate surfactant/emulsifying agents. The 
polymerisation occurs in micelles formed by the surfactants, which act as the seeding 
templates for the nanoparticles. After formation of a stable emulsion the organic solvent is 
evaporated resulting in the active compound being entrapped, encapsulated or attached to the 
nanoparticle matrix. This technology is widely used in industry in the formation of polymer 
latexes by radical polymerisation.  
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We have recently shown that it is also possible to use glycosylated block copolypeptides as 
macromolecular surfactants in the emulsion polymerization of styrene, a methodology we 
feel is readily applicable to other systems.
36
 It is by using the latter approach that we have 
proposed to prepare polypeptide based nanoparticles. Applying an emulsion polymerisation 
approach to synthesize these nanoparticles would open exciting new possibilities for the 
design of biocompatible carriers. The inherent difficulties associated with this approach are 
due to the instability of NCAs in the presence of moisture as well as the hydrophobic nature 
of the monomer when in the protected form. Here we report that by tailoring the 
emulsification conditions, the NCA ROP under emulsion polymerisation conditions is indeed 
possible and permits the synthesis of nanoparticles fully based on amino acids in a scalable 
process. 
5.2 Experimental 
5.2.1 Materials  
All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. ε-Benzyloxycarbonyl-L-lysine and DL-phenylalanine were supplied by Bachem. 
Anhydrous dichloromethyane (DCM), ethyl acetate, tetrahydrofuran (THF) and heptane were 
used directly from the bottle under an inert and dry atmosphere. ε-Benzyloxycarbonyl-L-
lysine (ZLL), Phenyl alanine (PA) and S-(o-nitrobenzyl)-L-cysteine (NBC) NCA was 
synthesised following literature procedures.
37-39
 
5.2.2 Synthesis of block copolypeptides PZLL47-b-PPA10  
The NCA monomer of ZLL (3.0 g, 9.8 mmol) was dissolved in 20 mL anhydrous DMF and 
transferred to a Schlenk tube. The solution was degassed via three successive freeze-pump-
thaw cycles and kept under vacuum. The reaction flask was immersed in a 0 °C water bath 
and a solution of 15 μL allylamine in 1 mL anhydrous DMF ([M]0/[I]0 = 35) was injected 
through a rubber septum with a syringe. The reaction was left to stir until the ZLL NCA had 
been completely consumed as monitored by ATR-FTIR spectroscopy. The polypeptide was 
further chain extended via the introduction of phenyl alanine NCA (0.38 g, 2.0 mmol, 
[M]0/[I]0 = 10) dissolved in 5 mL DMF. After full monomer conversion monitored via ATR 
FTIR spectroscopy the polymer was precipitated into an excess of diethyl ether, filtered and 
dried under vacuum. Isolated yield: 2.3 g.  
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5.2.3 Block copolypeptide deprotection  
A general procedure was used for the deprotection of the PZLL pendant groups. PZLL47-b-
PPA10 (2.0 g, 6.8 mmol ZLL repeat units) was dissolved in trifluoroacetic acid (15 mL). 3.5 
mL of HBr solution (33 wt.% in acetic acid; 3-fold excess with respect to the ZLL repeat 
units) was added slowly to the reaction at 0 °C. After 2 h, the solution was added to 300 mL 
diethyl ether and the precipitate washed three times with 50 mL diethyl ether. The product 
was dialyzed against distilled deionized (DDI) water using Spectra/Por dialysis membranes 
(MWCO, 3.5 kDa) for 72 h at room temperature. The product PLL47-b-PPA10 was lyophilized 
and isolated as a white powder. Isolated yield: 0.93 g.  
5.2.4 Glycosylation of PLL47-b-PPA10  
A general procedure for 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC)/N-hydroxysulfosuccinimide (Sulfo-NHS) coupling was employed to 
attach lactobionic acid to the lysine residues of the amphiphilic copolypeptide. Lactobionic 
acid (LA) (0.43 g, 1.2 mmol, 0.2 eq w.r.t the lysine repeat units), EDC (0.23 g, 1.2 mmol, 1 
eq w.r.t. LA) and sulfo-NHS (26 mg, 0.1 mmol, 0.1 eq w.r.t. EDC) were dissolved in 3 mL 
10 mM MES buffer (pH 4.7) and stirred for 20 minutes. The latter was added to a solution of 
PLL47-b-PPA10 (0.9 g, 0.12 mmol) in 7 mL of DDI water. The reaction mixture was stirred 
overnight. The resulting product was purified via dialysis against DDI water using 
Spectra/Por dialysis membranes (MWCO, 3.5 kDa) for 72 h at room temperature. The 
product was subsequently lyophilized and isolated as a white powder. Isolated yield: 1.2 g. 
5.2.5 Preparation of polypeptide latex via mini-emulsion polymerization 
The polypeptide NPs where prepared via the miniemulsion polymerization of N-
carboxyanhydrides stabilized in an aqueous environment with glycosylated amphiphilic 
copolypeptides. The copolypeptide, (LA12-r-PLL35)-b-PPA10 (80 mg, 6.8 x 10
-6
 mol), was 
dissolved in 8 mL of 2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH 4.5, 0.1 M) and 
the solution cooled in an ice bath for 5 min under magnetic stir. The NBC NCA (190 mg, 0.7 
mmol) was dissolved in 1.5 mL DCM and introduced into the aqueous system dropwise via 
syringe while under heavy stir (Turrax homogenizer). The reaction mixture was left under 
heavy stir using a T 10 basic ULTRA-TURRAX® homogenizer for 5 min, while being kept 
in the ice bath. Triethylamine (7 uL) was subsequently added to the reaction to initiate the 
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reaction and left under magnetic stir for 5 hours at room temperature. The reaction mixture 
was then subjected to high vacuum rotary evaporation to remove the organic solvent, DCM. 
The resulting latex was dialyzed against DDI for 24 hours using Spectra/Por dialysis 
membranes (MWCO, 3.5 kDa).  
5.2.6 Methods 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance 400 (400 
MHz) in DMSO-d6 and CDCl3 as solvents. All chemical shifts are reported in parts per 
million (ppm) with tetramethylsilane (TMS) as an internal reference. Attenuated Total 
Reflection (ATR) FTIR measurements were performed on a Perkin-Elmer Spectrum 100 
instrument. Spectra were obtained from 4 scans with a resolution of 2 cm
-1
 in the spectral 
region of 650 – 4000 cm-1. A background measurement was taken before the sample was 
loaded onto the ATR for measurement. Samples could be characterized in the liquid state 
without prior sample preparation. Size Exclusion Chromatography (SEC) was performed on 
an Agilent 1200 system in conjunction with two PSS GRAM analytical (8 x 300 and 8 x 100, 
10 μ) columns, a Wyatt Dawn Heleos 8 multi angle light scattering (MALS) detector and 
Wyatt Optilab rEX differential refractive index (DRI) detector with a 658 nm light source. 
The eluent was DMF containing 0.1 M LiBr at a flow rate of 1 mL/min. The column 
temperature was set to 40 °C with the MALS detector at 35 °C and the DRI detector at 40 °C. 
Molar masses and dispersities were calculated from the MALS signal by the Astra software 
(Wyatt) using the refractive index increment (dn/dc) as calculated relative to the ratio of the 
homopolymer. The dn/dc values used for the polymers were experimentally determined or as 
found in literature.
40, 41
 All samples for SEC analysis were filtered through a 0.45 mm PTFE 
filter (13 mm, PP housing, Whatman) prior to injection. Dynamic light scattering (DLS) 
experiments were performed at 25°C on a Malvern NanoZS (Malvern Instruments, Malvern 
UK) which uses a detection angle of 173°, and a 3 mW He-Ne laser operating at a 
wavelength of 633 nm. Cryogenic transmission electron microscopy (cryo-TEM) 
measurements were performed on an FEI Tecnai 20, type Sphera TEM instrument equipped 
with a LaB6 filament operating at 200 kV. Images were recorded with a bottom-mounted 
Gatan CCD camera. The sample vitrification procedure was carried out using an automated 
vitrification robot (FEI Vitrobot Mark III). A 3 μL sample was applied on a Quantifoil grid 
(R 2/2, Quantifoil Micro Tools GmbH; freshly glow-discharged just prior to use), excess 
liquid was blotted away, and the formed thin film was shot into melting ethane. The grid 
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containing vitrified film was immediately transferred to a cryoholder (Gatan 626) and 
observed at −170 °C. 
5.3 Results and discussion  
Working towards fully biodegradable nanoparticles from the styrene system described in 
Chapter 4, the question was whether it is possible to replace the synthetic styrene core with a 
polypeptide based alternative. In a 1998 patent Makino et al. disclosed the synthesis of solid 
poly-α-amino acid particles via an oil-in-water emulsion consisting of water, water 
immiscible organic solvent and NCA monomer in the presence of an emulsifier, 
polyoxyethylene sorbitane monolaurate (Tween 20) and triethylamine.
42
 Initial attempts of 
recreating their results by simply replacing the emulsifier with a polypeptides based one 
where all unsuccessful. The major constraints faced with a classical emulsion polymerisation 
approach were the initial introduction of the NCA monomer into an aqueous environment 
without pre-maturely initiating the monomer solution as well as the monomer transport into 
the growing particles. Under these conditions it was repeatedly observed that the monomer 
precipitated from solution resulting in a heterogeneous mixture of hydrophobic polypeptide 
and water.  
It was envisioned that the normal diffusion based transport mechanism of monomer in an 
emulsion polymerization system would not suffice as this could lead to early initiation of the 
monomer and/or possibly no diffusion of the bulky monomer towards the stabilized 
polypeptide particles. It was thus decided to change the synthetic approach and rather utilize 
a miniemulsion polymerization, in which the monomer is encapsulated into preformed 
micelles. These subsequently act as particles seeds in the polymerisation process. 
Miniemulsions are produced by the introduction of a high shear force typically provided by a 
sonicator or mechanical homogenizer. The emulsion droplets are broken up into sub-micron 
particles stabilized by surfactant and/or co-stabilizer molecules. Effective stabilization of the 
droplets is necessary to ensure predominant droplet nucleation. While the surfactant retards 
coalescence of droplets, the costabilizer inhibits Ostwald ripening, a phenomena where the 
monomer diffuses from smaller droplets to larger ones, resulting in creaming of the latex. 
Due to the hydrophobicity of the NCA monomer along with the relatively low chance of 
diffusion from the bulky molecule it was expected that a costabilizer was unnecessary 
allowing the design of a system whereby ultimately we would obtain fully amino acid and 
carbohydrate based nanoparticles.    
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5.3.1. Synthesis of the glycosylated block copolypeptides  
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Scheme 5. 1 General strategy towards the glycosylated block copolypeptide, (LA12-r-
PLL35)-b-PPA10. 
The emulsification was tailored to proceed under acidic conditions so as to ensure that the 
NCA would remain stable once dispersed in the aqueous phase. Under these conditions, 
poly(L-lysine) (PLL) would be most suitable for the hydrophilic block as the amino moieties 
could be protonated ensuring a random coil formation to further enhance the solubility of the 
amphiphile. Moreover, it was necessary that the hydrophobic block would not be hydrolysed 
as this would inadvertently affect the hydrophilic-lipophilic balance.
43
 Therefore, 
poly(phenylalanine) (PPA) was chosen to be incorporated inside the core of the nanoparticle 
and amphiphilic copolypeptides to be used as macromolecular surfactants were prepared in a 
similar fashion as reported before.
36
. Sun et al. have shown that PLL-b-PPA copolypeptides 
of c.a. 10 PPA repeat units readily self-assemble into giant vesicles and theoretically paving 
the way towards templated designs.
38
 Based on these results, it was thought to be a promising 
system for the stabilization of particles and the formation of a stable emulsion. 
The option of glycosylating the block copolypeptides was primarily to increase the 
hydrophilicity of the copolypeptides as reported in previous work where it lead to improved 
water solubility over a broad pH range. Accordingly, we prepared the amphiphilic 
copolypeptides, (LA12-r-PLL35)-b-PPA10 (Scheme 5.1) and further characterised with 
1
H-
NMR spectroscopy and SEC. 
1
H-NMR (DMSO-d6, 
1
H-NMR not shown) was used to 
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quantify the repeat units of the PZLL of the PPA backbone by referencing the methylene 
protons of the two polypeptide segments (5.1 and 2.9 ppm respectively) to that of the single 
allylic methine proton from the initiator (5.65 ppm). The degree of glycosylation was 
quantified by referencing the protons from the galactose moiety (Figure 5.1, S1-11) to that of 
the methylene protons on the PLL backbone (Figure 5.1, C). Furthermore, a narrow and 
monomodal distribution is evident from the SEC trace (Figure 5.2) highlighting the 
successful synthesis of the block copolypeptide.  
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Figure 5. 1  
1
H-NMR spectra (D2O, 400 MHz) of (LA12-r-PLL35)-b-PPA10. 
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Figure 5. 2 SEC trace of the PZLL47-b-PPA10 copolypeptide. 
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5.3.2. Polypeptide NP synthesis 
The experimental procedure for the synthesis of the polypeptide NPs involved solubilizing 
the electrolytic surfactants into an amine free MES buffer (pH 4.5) and cooling the solution 
down. The monomer chosen was a photoresponsive S-(o-nitrobenzyl)-L-cysteine (NBC) 
NCA, which would allow for post polymerization crosslinking the particle core thereby 
increasing the particle stability (see Scheme 5.2).  
 
Scheme 5. 2 Cartoon showing the generalized reaction scheme for the synthesis of the 
PNBC NP before and after UV radiation, leading to a core cross-linked polypeptide NP. 
It is understood that the NCA ROP follows two reaction mechanisms, a controlled normal 
amine mechanism (NAM) and the other, an uncontrolled base catalysed reaction (activated 
monomer mechanism, AMM).
20, 44, 45
 Both mechanisms were utilized in this process to 
compare the slower controlled propagation of the NAM against that of the fast and 
uncontrolled AMM.  
For the NAM and AMM type reactions, the copolypeptide and MES buffer solution was 
cooled down in an ice bath prior to the introduction of the monomer, after which the reaction 
was left to proceed at room temperature while stirring magnetically.To promote the NAM, a 
nucleophilic initiator, hexylamine, was introduced to a separate DCM solution containing the 
NCA monomer just prior emulsification. The latter was achieved via dropwise addition of the 
monomer/initiator reaction mixture into the surfactant solution while under heavy mechanical 
stir (utilizing a high powered homogenizer).  
Typically, conversion during NCA ROP polymerization is measured with ATR-FTIR 
spectroscopy by following the disappearance of the initial NCAs anhydride peaks (1850 and 
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1790 cm
-1
). The current system does not allow for this method and consequently the progress 
of the reaction was visually monitored by bubbling the evolving CO2 through an attached 
vial. After no CO2 was produced anymore, the reaction was left to stir for another hour. 
Sample purification involved removing the MES buffer as well as the water-immiscible 
organic solvent. This involved dialysis to obtain a solution with neutral pH while removing 
DCM under vacuum (care was taken to do this progressively to not rupture the particles). 
In all our attempts, we could not isolate a single distribution of products (even after 
purification attempts) and ultimately found that this procedure resulted in a multimodal 
distribution of particles sizes (see figure 5.3). DLS characterization during the initial stages of 
the reaction showed a monomodal distribution of particles, only to grow in disparity as the 
reaction progressed. It was therefore speculated that the mechanism was too slow and phase 
separation occurred, resulting in a distribution of particles.  
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Figure 5. 3  Dynamic light scattering traces of the intensity distributions directly after 
emulsification of the NCA/DCM solution (red) as well as after completion of the reaction 
(black), using hexylamine as the initiator. 
Cryogenic TEM was utilized to obtain a clearer image of the particles in their hydrated state 
which resulted in some very interesting images regarding the morphology of the particles. 
Figure 5.4 depicts the heterogeneity we obtained when using the hexylamine initiator where a 
subsequent distribution of particle sizes and morphologies was observed. What was obtained 
could most accurately be described as ‘jellyfish’ like structures. It was found that the particle 
morphology strived towards this jellyfish like deformation, the extent of which is seemingly 
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size dependent as it is only noticeable above a threshold size. It should be noted that in all 
three of these images, the latex has only been dialysed and that DCM is still present. This 
makes the structure more pronounced, revealing the level of intricacy present. In image B the 
three main morphologies generally encountered with this preparation method can be seen in 
one slide. The smaller particles were attributed to particles of mainly DCM with little to no 
polymer present.   
 
Figure 5. 4  Cryo-TEM images of the PNBC nanoparticles initiated via hexylamine, 
showing a distribution of different morphologies dependent on the particle size.   
It was hypothesized that the specific characteristics of the hexylamine initiation (AMM) 
might be responsible for the size distribution and non-uniform shape of the particles. 
Typically this polymerisation is slow, which might open the door for various mechanical and 
chemical influences affecting the particles formation over the reaction time. Modeling the 
approach on the clasical radical emulsion polymerisation, which is a very fast process, it was 
decided to try and exploit the activated monomer mechanism in an attempted to ‘capture’ the 
particles directly after applying the high shear force. This is necessary as the monomer 
droplets are not thermodynamically stable. In contrast to the previous approach, the initiator 
was only added after the formation of a stable DCM/monomer emulsion. This was achieved 
via dropwise addition of the monomer solution into the surfactant/MES buffer mixture while 
under heavy mechanical stir. That means that only after preparing the stabilized emulsion was 
the initiator (triethylamine) added to the reaction mixture. The basic nature of TEA leads to 
proton abstraction from the nitrogen atom of the monomer resulting in an anion NCA, the 
result of which is fast and uncontrolled propagation, a characteristic of the AMM.  
Figure 5.5 shows the DLS traces directly before and after the introduction of the initiator as 
well as the progression of the particle distributions as a function of time. We see in all cases a 
single distribution, which is consistent right through the reaction with minimal change in the 
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particle size as the reaction proceeds to completion. This would seem to indicate that the 
initial droplets formed using the homogeniser acts as seeds for the growing particles which 
are effectively stabilized by the glycosylated copolypeptides. Table 5.1 represents a summary 
of the characterization results from DLS.    
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Figure 5. 5  Dynamic light scattering traces of the normalized intensity distributions of the 
polypeptide nanoparticles as a function of time after the addition of the initiator, 
triethylamine.  
The images in figure 5.6 show the particles synthesized after purification (no DCM present), 
using TEA as initiator. Image A is a snapshot of what the majority of particles looked like 
while images B and C show the close-up. The difference in densities throughout the particles 
is quite evident with what looks like a collection of collapsed tunnels. It is known that 
poly(L-cysteine) exclusively assume β-sheet confirmations, where this has been shown to be 
true for PNBC homopolymer as well.
39, 44
 It was therefore argued that these regions of higher 
(density) could be attributed to the secondary structure of the polypeptide. This is a 
characteristic which becomes more pronounced with larger particles, possibly due to more 
monomer being encapsulated in particles resulting in an increase in the repeating units and 
subsequently cumulating the effect of the β-sheet formation. 
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Figure 5. 6  Cryo-TEM images of the PNBC nanoparticles initiated via triethylamine, 
resulting in a monomodal distribution of UV reactive nanoparticles. 
Future work would involve influencing particle size and increasing control of the distribution 
of products, characteristics we expect to be dependent on how the emulsion is prepared at the 
start of the reaction. This would of course be directly correlated to the amount of surfactant 
present to act as particle stabilizer as well as the effectiveness of the high shear dispersion 
method used initially where it can be assumed that a better dispersion tool would lead to a 
narrower distribution of products.  
Figure 5.7 shows a monomodal particle distribution after purification with decrease in 
diameter as well as narrower distribution when compared to the NP directly after synthesis 
(see Table 5.2). The significant decrease in the PDI after purification is most likely due to the 
removal of dispersed DCM outside the NPs. It is expected that some heterogeneous phase 
separation will occur as propagation proceeds due to the insolubility of the polypeptide, 
PNBC in DCM.    
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Table 5. 1  Summary of the DLS characterization data for the polypeptide nanoparticles 
as a function of time after the addition of the initiator, triethylamine.   
Reaction time 
(min) 
Temp 
(°C) 
Z-Ave 
(d.nm) 
PDI 
Peak Area 
(percent) 
0 25 195 0.10 100 
20 25 200 0.16 100 
40 25 205 0.21 100 
60 25 204 0.24 100 
100 25 200 0.19 100 
200 25 202 0.20 100 
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Figure 5. 7 Dynamic light scattering traces of the intensity and volume distributions of the 
polypeptide nanoparticles after purification. 
In a subsequent procedure we aimed to prepared stable, cross-linked particles by subjecting 
the polypeptide latex to UV light. This was done to cleave the UV labile o-nitrobenzyl groups 
inside the core of the polypeptide NPs (Scheme 5.2 C). It was expected that this would result 
in the formation of disulfide bridges leading to denser particles. Upon UV irradiation, DLS 
confirmed a significant decrease in particle size of 20 nm, that is from 196 nm to 176 nm 
(Figure 5.8 and Table 5.2).   
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Figure 5. 8  Dynamic light scattering traces the intensity distributions before (black) and 
after (red) exposure to a UV source, resulting in a decrease of the particle diameter. 
  
Complimentary to the DLS results, Cryo-TEM images show a clear change in morphology 
after being subjected to UV radiation (Figure 5.9). The decrease in particle diameter as the 
core is cross-linked is quite clear and subsequently leads to a seemingly denser and more 
compact particle. 
 
Figure 5. 9 Cryo-TEM images of the PNBC nanoparticles after exposure to UV light. A 
sharp decrease in size was observed leading to a denser, more compact cross-linked 
nanoparticle. 
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Table 5. 2  Summary of the DLS characterization data for the polypeptide nanoparticles 
after purification and exposure to UV. 
Polypeptide NP Temp (°C) 
Z-Ave 
(d.nm) 
PDI 
Peak Area 
(percent) 
PNBC NP (with DCM) 25 202 0.20 100 
PNBC NP (Purified) 25 196 0.11 100 
PNBC NP after UV exposure 25 176 0.12 100 
 
 
 
5.4 Conclusion 
Glycosylated block copolypeptides have been shown to be effective stabilizers in the 
preparation of fully amino acid and sugar based nanoparticles. A UV responsive NCA, S-(o-
nitrobenzyl)-L-cysteine (NBC), was successfully polymerized by a mini-emulsion 
polymerization process in aqueous conditions to prepare narrowly distributed, PNBC 
nanoparticles. Furthermore, it was shown that propagation kinetics as determined by the type 
of initiator and thus the type of propagation mechanism plays a crucial part in ensuring a 
monomodal distribution of products.    
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Chapter 6 
6.1 Conclusions and future outlook 
The aim of this PhD was to expand the reach of synthetic polypeptide based materials with 
potential utilization in existing technologies as green alternatives. Specifically, we wanted to 
incorporate polypeptides in the synthesis of nanoparticles as fully biocompatible and 
biodegradable surfactants or emulsifiers.  
In Chapter 2 we demonstrated the versatility of combining reversible addition-fragmentation 
chain transfer (RAFT) mediated polymerization and the ring-opening polymerization (ROP) 
of N-carboxyanhydrides (NCAs) in the synthesis of polypeptide-polymer hybrids. Key to this 
successful approach was an end-group engineering strategy that prevents the simultaneous 
presence of amino and CTA groups. We devised two such strategies, which are simple and 
highly efficient, i.e. the aminoethanol CTA removal with in-situ thiolactone formation for 
PBA and simultaneous aminolysis/thiol-ene reaction with hydroxyl ethylacrylate for PS and 
PNIPAM. The combination of these two polymerization techniques have shown to be 
effective in synthesizing a wide range of hybrid conjugates only limited by the compatibility 
of the RAFT CTA and monomer while the presented end-capping strategies allow the 
introduction of a range of functional end-groups. 
In the third chapter we apply our strategy in preparing well-defined polymer-polypeptide 
conjugates and illustrate the versatile nature of these hybrid conjugates as well as potential 
applications. In this approach, hybrid block copolymers consisting of poly(styrene) and 
poly(amino acid) segments were synthesized via the combination of RAFT and NCA 
polymerization. The polypeptide segments were glycosolated with galactose moieties using 
traditional coupling chemistry. The resulting amphiphilic block copolymers were found to be 
efficient stabilizers in the emulsion polymerization of styrene offering a facile method for the 
synthesis of fluorescent glycosylated polystyrene nanoparticles. The availability of the 
galactose units introduced through the glycopolymer surfactant at the nanoparticles surface 
for selective binding was successfully demonstrated by lectin binding experiments and 
binding to Chinese hamster ovary (CHO) cells. This approach provided a straightforward 
route to highly fluorescent nanoparticles with selective binding properties for imaging 
applications avoiding particle post-modification. 
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The fourth chapter was a step towards greener surfactants, where the aim was utilize fully 
amino acid based stabilizers in synthetic emulsion systems. Block copolymers consisting of 
poly(L-phenyl alanine) and partially glycosylated poly(L-glutamic acid) and poly(L-lysine), 
respectively, were synthesized via sequential NCA polymerization and subsequent polymer 
glycosylation. The resulting amphiphilic block copolypeptides were found to be efficient 
stabilizers in the emulsion polymerization of styrene offering a facile method for the 
synthesis of polystyrene nanoparticles. This signifies an example of functional polymer 
additives fully based on renewable building blocks in materials applications. 
The last part of the work is a culmination of the knowledge gained right through the PhD 
study. Chapter 5 is the answer to a question which initiated this whole study – “Is it possible 
to prepare solid nanoparticles consisting entirely of amino acid based building block?” This 
has been partly answered as we have shown that glycosylated block copolypeptides are 
effective stabilizers in the preparation of fully amino acid and sugar based nanoparticles. A 
UV responsive NCA, S-(o-nitrobenzyl)-L-cysteine (NBC), was successfully polymerized by 
a mini-emulsion polymerization process in aqueous conditions to prepare narrowly 
distributed, PNBC nanoparticles. Furthermore, it was shown that propagation kinetics as 
determined by the type of initiator and thus the type of propagation mechanism plays a 
crucial part in ensuring a monomodal distribution of products.    
The future outlook of this work can only be described as positive, particularly the work done 
in chapter 5. Here, the emphasis should be on the expansion of knowledge regarding the 
synthesis of these polypeptide nanoparticles. These materials hold high potential as a next 
generation nanoparticle platform with real world applications if the processing methodology 
can be further developed and refined.  
Furthermore, with the immense array of synthetic tools available it is possible to introduce 
novelty and “smart” features to these materials. This opens a path for these polypeptide NPs 
as next generation carrier systems with vast potential in functionalizability to readily enable 
loading with multiple classes of active agents, allow chemical modification, bio-conjugation 
or diagnostic labelling. 
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Appendix A 
CD spectroscopy data (see Chapter 4) 
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Figure A. 1 CD spectra of aqueous solutions of GA28-r-PLGA32-b-PPA20 as a function of pH. 
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Figure A. 2 CD spectra of aqueous solutions of PGL7-b-PBLG56-b-PPA19 as a function of 
pH. 
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Figure A. 3 CD spectra of aqueous solutions of Gal7-b-PBLG56-b-PPA19 as a function of 
pH. 
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Figure A. 4 CD spectra of aqueous solutions of PLL59-b-PPA24 as a function of pH. 
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Figure A. 5 CD spectra of aqueous solutions of LA17-r-PLL42-b-PPA24 as a function of pH. 
 
